This is a Validated Antibody Database (VAD) review about human CD19, based on 522 published articles (read how Labome selects the articles), using CD19 antibody in all methods. It is aimed to help Labome visitors find the most suited CD19 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD19 synonym: B4; CVID3

Knockout validation
BioLegend
mouse monoclonal (HIB19)
  • immunocytochemistry knockout validation; human; loading ...; fig 5a
BioLegend CD19 antibody (BioLegend, HIB19) was used in immunocytochemistry knockout validation on human samples (fig 5a). EMBO J (2018) ncbi
BioLegend
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...
BioLegend CD19 antibody (Biolegend, SJ25C1) was used in flow cytometry on human samples . J Exp Med (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 4a
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 4a). Mol Cancer Ther (2022) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s2c
BioLegend CD19 antibody (Biolegend, 363036) was used in flow cytometry on human samples (fig s2c). Nat Commun (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD19 antibody (Biolegend, 302206) was used in flow cytometry on human samples (fig s1). Front Med (Lausanne) (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4j
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 4j). Nature (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1f, s1b
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1f, s1b). MBio (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples at 1:100 (fig 1a). Signal Transduct Target Ther (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig 6b
BioLegend CD19 antibody (Biolegend, 302224) was used in flow cytometry on human samples at 1:100 (fig 6b). Nat Nanotechnol (2022) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; 1:100; fig 4i
BioLegend CD19 antibody (Biolegend, 392504) was used in flow cytometry on human samples at 1:100 (fig 4i). Nat Med (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:400; loading ...
BioLegend CD19 antibody (BioLegend, 302254) was used in flow cytometry on human samples at 1:400. Cell (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (Biolegend, 302230) was used in flow cytometry on human samples . Cell Host Microbe (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on mouse samples (fig 3d). Nat Commun (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 7
BioLegend CD19 antibody (Biolegend, 302216) was used in flow cytometry on human samples (fig 7). PLoS Negl Trop Dis (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1c
BioLegend CD19 antibody (Biolegend, 302215) was used in flow cytometry on human samples (fig 1c). Transl Oncol (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD19 antibody (Biolegend, 302206) was used in flow cytometry on human samples (fig 5a). J Clin Invest (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:200; loading ...; fig s1a
BioLegend CD19 antibody (Biolegend, 302218) was used in flow cytometry on human samples at 1:200 (fig s1a). Arthritis Res Ther (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD19 antibody (Biologend, 302207) was used in flow cytometry on human samples (fig 1b). Sci Rep (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples at 1:100. Nature (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples . Aging Cell (2021) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; fig s3b
BioLegend CD19 antibody (Biolend, 4G7) was used in flow cytometry on human samples (fig s3b). Front Immunol (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD19 antibody (Biolegend, 363006) was used in flow cytometry on human samples (fig s1b). BMC Biol (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD19 antibody (BioLegend, 302270) was used in flow cytometry on human samples (fig s1b). Immunity (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (Biolegend, H1B19) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend CD19 antibody (Biolegend, 302207) was used in flow cytometry on mouse samples (fig 2c). J Autoimmun (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD19 antibody (Biolegend, 302216) was used in flow cytometry on human samples (fig s2). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2a
BioLegend CD19 antibody (Biolegend, 302237) was used in flow cytometry on human samples (fig s2a). Cell (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s3i
BioLegend CD19 antibody (BioLegend, 363006) was used in flow cytometry on human samples (fig s3i). Cell (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s4-1
BioLegend CD19 antibody (Biolegend, 302247) was used in flow cytometry on human samples (fig s4-1). elife (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1b). Arthritis Res Ther (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig st2
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig st2). EBioMedicine (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig 2a
BioLegend CD19 antibody (BioLegend, 302242) was used in flow cytometry on human samples at 1:100 (fig 2a). elife (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 2a). Science (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 4a). J Clin Invest (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; 1:500; loading ...; fig s1b
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on mouse samples at 1:500 (fig s1b). Blood (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1d). JCI Insight (2020) ncbi
mouse monoclonal (HIB19)
  • mass cytometry; human; loading ...; fig 1c
BioLegend CD19 antibody (Biolegend, 302247) was used in mass cytometry on human samples (fig 1c). Front Oncol (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BioLegend CD19 antibody (BioLegend, 302210) was used in flow cytometry on human samples . Nature (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD19 antibody (BioLegend, 302218) was used in flow cytometry on human samples (fig 4b). Stem Cell Reports (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s20
BioLegend CD19 antibody (Biolegend, 302216) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD19 antibody (Biolegend, 302224) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:200; loading ...; fig 1s1a
BioLegend CD19 antibody (BioLegend, 302244) was used in flow cytometry on human samples at 1:200 (fig 1s1a). elife (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD19 antibody (BioLegend, SJ25C1) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s14b
BioLegend CD19 antibody (Biolegend, SJ25C1) was used in flow cytometry on human samples (fig s14b). Science (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig e4f
BioLegend CD19 antibody (Biolegend, 302203) was used in flow cytometry on human samples at 1:100 (fig e4f). Nature (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:50; loading ...; fig 6c
BioLegend CD19 antibody (BioLegend, 302233) was used in flow cytometry on human samples at 1:50 (fig 6c). Nat Commun (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2d
BioLegend CD19 antibody (Biolegend, 302202) was used in flow cytometry on human samples (fig s2d). Cell (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD19 antibody (BioLegend, 302247) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig ex2c
BioLegend CD19 antibody (BioLegend, SJ25C1) was used in flow cytometry on human samples (fig ex2c). Nature (2019) ncbi
mouse monoclonal (HIB19)
  • immunohistochemistry; human; loading ...; fig 2b
BioLegend CD19 antibody (BioLegend, 302201) was used in immunohistochemistry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s2o
BioLegend CD19 antibody (Biolegend, 363020) was used in flow cytometry on human samples (fig s2o). JCI Insight (2019) ncbi
mouse monoclonal (HIB19)
  • other; human; loading ...; fig 4b
BioLegend CD19 antibody (BioLegend, 302259) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a, 1d
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1a, 1d). Front Immunol (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig 2c
BioLegend CD19 antibody (Miltenyi, 302256) was used in flow cytometry on human samples at 1:100 (fig 2c). elife (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig s1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig s1a, s3b
BioLegend CD19 antibody (Biolegend, 302246) was used in flow cytometry on human samples at 1:100 (fig s1a, s3b). Cancer Cell (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 2 ug/ml; loading ...; fig s13
BioLegend CD19 antibody (BioLegend, 302211) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s7b
BioLegend CD19 antibody (BioLegend, 302216) was used in flow cytometry on human samples (fig s7b). J Clin Invest (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig ex1a
BioLegend CD19 antibody (Biolegend, 363004) was used in flow cytometry on human samples (fig ex1a). Nature (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD19 antibody (Biolegend, 302225) was used in flow cytometry on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig s1). Nat Immunol (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 5a). Immunol Cell Biol (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 9d
BioLegend CD19 antibody (BioLegend, 302210) was used in flow cytometry on human samples (fig 9d). J Exp Med (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on mouse samples (fig 2d). Ann Rheum Dis (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s3c
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig s3c). Transl Oncol (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD19 antibody (BioLegend, 302246) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s6d
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig s6d). Cell (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s18b
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig s18b). Science (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; 1:60; loading ...; fig 7a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on mouse samples at 1:60 (fig 7a). J Virol (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (HIB19)
  • immunocytochemistry knockout validation; human; loading ...; fig 5a
BioLegend CD19 antibody (BioLegend, HIB19) was used in immunocytochemistry knockout validation on human samples (fig 5a). EMBO J (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...; fig s13b
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on mouse samples (fig s13b). J Clin Invest (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 6a). Sci Rep (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 4a). Oncotarget (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend CD19 antibody (biolegend, HIB19) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s4a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig s4a). J Immunol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, BioLegend CD19 antibody (BioLegend, 302232) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1a). Sci Rep (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 7c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD19 antibody (BioLegend, 302232) was used in flow cytometry on human samples (fig 7c). Immunity (2017) ncbi
mouse monoclonal (HIB19)
  • mass cytometry; human; loading ...; fig 1h
In order to map the lineage of human dendritic cells, BioLegend CD19 antibody (Biolegend, HIB19) was used in mass cytometry on human samples (fig 1h). Science (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1e
BioLegend CD19 antibody (Biolegend, 302216) was used in flow cytometry on human samples (fig 1e). J Extracell Vesicles (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1a
BioLegend CD19 antibody (BioLegend, 302234) was used in flow cytometry on human samples (fig 1a). J Autoimmun (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD19 antibody (BioLegend, 302206) was used in flow cytometry on human samples (fig 2e). Sci Rep (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1a
In order to determine the localization of FcgammaRI, FcgammaRII, and SIRPalpha in macrophages, BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig s1a). J Cell Biol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig s3a). Sci Rep (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD19 antibody (BioLegend, 363029) was used in flow cytometry on human samples (fig 3a). Oncoimmunology (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1d
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig s1d). Clin Immunol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig S1
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BioLegend CD19 antibody (Biolegend, 30221) was used in flow cytometry on human samples (fig S1). Front Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1c
In order to assess the frequencies of liver-infiltrating antibody-secreting B cells in primary biliary cholangitis and primary sclerosing cholangitis, BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1c). J Autoimmun (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2a
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD19 antibody (Biolegend, 302212) was used in flow cytometry on human samples (fig 1d). Cell (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1
In order to identify cells that respond to interferon lambda, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s6a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig s6a). J Clin Invest (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s5a
BioLegend CD19 antibody (Biolegend, 302215) was used in flow cytometry on human samples (fig s5a). Sci Rep (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
In order to examine the interaction between Trichomonas vaginalis and human immune cells, BioLegend CD19 antibody (Biolegend, HIN19) was used in flow cytometry on human samples (fig 1). PLoS Negl Trop Dis (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:200; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples at 1:200 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD19 antibody (Biolegend, HIB-19) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples . elife (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 6a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s5b
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig s5b). Eur J Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD19 antibody (BioLegend, 302242) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (HIB19)
  • mass cytometry; human; loading ...; tbl 1, 2
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, BioLegend CD19 antibody (Biolegend, HIB19) was used in mass cytometry on human samples (tbl 1, 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (HIB19)
  • immunocytochemistry; human; loading ...; fig 3
BioLegend CD19 antibody (Biolegend, 302202) was used in immunocytochemistry on human samples (fig 3). J Immunol Methods (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1a). Nat Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...; fig 6b
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on mouse samples (fig 6b). J Exp Med (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1b
In order to develop a method to detect circulating B cells that recognize nuclear antigens in patients, BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 1b). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1d
In order to study the effect of anti-SLAMF6 antibody and ibrutinib on chronic lymphocytic leukemia cells, BioLegend CD19 antibody (biolegend, HIB 19) was used in flow cytometry on human samples (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1). J Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BioLegend CD19 antibody (Biolegend, 302210) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; 1:100
In order to assess the role of NLRC5 to NK-T-cell crosstalk, BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD19 antibody (biolegend, HIB19) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 8b
BioLegend CD19 antibody (Biolegend,, 302228) was used in flow cytometry on human samples (fig 8b). PLoS ONE (2015) ncbi
mouse monoclonal (HIB19)
BioLegend CD19 antibody (Biolegend, 302219) was used . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 5
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s2
In order to elucidate how hepatitis C virus infection alters B cell proliferation, BioLegend CD19 antibody (Biolegend, 302205) was used in flow cytometry on human samples (fig s2). Oncogene (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BioLegend CD19 antibody (Biolegend, 302216) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BioLegend CD19 antibody (BioLegend, H1B19) was used in flow cytometry on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (HIB19)
In order to elucidate the mechanism by which IFN-beta1b suppresses relapsing-remitting multiple sclerosis, BioLegend CD19 antibody (Biolegend, HIB19) was used . Clin Exp Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (BioLegend, 302216) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:200
In order to develop a system to determine human DC development and differentiation, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples at 1:200. J Immunol Methods (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (Biolegend, 302208) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 5
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples (fig 5). J Exp Med (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend CD19 antibody (biolegend, 302235) was used in flow cytometry on human samples (fig s2). PLoS Pathog (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 5
BioLegend CD19 antibody (Biolegend, # 302205) was used in flow cytometry on human samples (fig 5). Biomaterials (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BioLegend CD19 antibody (Biolegend, clone HIB19) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; tbl s1
BioLegend CD19 antibody (Biolegend, SJ25C1) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; tbl s1
BioLegend CD19 antibody (Biolegend, HiB19) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (Biolegend, 302226) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (Biolegend, 302223) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1). Int Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1). J Exp Med (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (HIB19)
BioLegend CD19 antibody (BioLegend, HIB19) was used . Blood (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BioLegend CD19 antibody (BioLegend, 302225) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (HIB19)
BioLegend CD19 antibody (Biolegend, 302217) was used . J Vis Exp (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (BioLegend, HIB19) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (HIB19)
BioLegend CD19 antibody (BioLegend, HIB19) was used . J Exp Med (2014) ncbi
mouse monoclonal (HIB19)
BioLegend CD19 antibody (BioLegend, HIB19) was used . Nat Commun (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BioLegend CD19 antibody (Biolegend, HIB19) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend CD19 antibody (BioLegend, 302206) was used in flow cytometry on human samples . Nat Med (2014) ncbi
Invitrogen
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig s3). Blood Adv (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig 1b). Arthritis Res Ther (2021) ncbi
domestic rabbit monoclonal (SP110)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 1c
Invitrogen CD19 antibody (Invitrogen, MA5-16414) was used in immunohistochemistry on mouse samples at 1:50 (fig 1c). J Autoimmun (2021) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; loading ...; fig 3c
Invitrogen CD19 antibody (ThermoFisher, MHCD1920) was used in flow cytometry on human samples (fig 3c). Science (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s2a
Invitrogen CD19 antibody (ThermoFisher, 56-0198-42) was used in flow cytometry on human samples (fig s2a). Cell (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 5b
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig 5b). Cell Death Dis (2020) ncbi
rat monoclonal (6OMP31)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 2d
Invitrogen CD19 antibody (Thermo Fisher, 60MP31) was used in immunohistochemistry on mouse samples at 1:500 (fig 2d). Sci Rep (2020) ncbi
rat monoclonal (6OMP31)
  • immunohistochemistry; mouse; loading ...; fig 1f
Invitrogen CD19 antibody (Thermo Fisher Scientific, 14-0194-82) was used in immunohistochemistry on mouse samples (fig 1f). World J Gastroenterol (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:50; loading ...; fig 1d
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples at 1:50 (fig 1d). elife (2020) ncbi
rat monoclonal (6OMP31)
  • immunohistochemistry - paraffin section; human; 0.5 ug/ml; fig 4a
Invitrogen CD19 antibody (Thermo Fisher, 14-0194-82) was used in immunohistochemistry - paraffin section on human samples at 0.5 ug/ml (fig 4a). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD19 antibody (ThermoFisher, 48-0198-42) was used in flow cytometry on human samples (fig 2a). Cell (2019) ncbi
rat monoclonal (6OMP31)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6d
Invitrogen CD19 antibody (Invitrogen, 60MP31) was used in immunohistochemistry - paraffin section on mouse samples (fig 6d). J Clin Invest (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:1; fig s4
Invitrogen CD19 antibody (EBioscience, 53-0199-42) was used in flow cytometry on human samples at 1:1 (fig s4). Nat Commun (2019) ncbi
mouse monoclonal (HD37)
  • flow cytometry; human; loading ...; fig 1c
Invitrogen CD19 antibody (Thermo Fisher, MA1-34005) was used in flow cytometry on human samples (fig 1c). Mol Cell Biol (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1a
Invitrogen CD19 antibody (eBioscience, 48-0199-42) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 8a
Invitrogen CD19 antibody (eBioscience, 11-0199-42) was used in flow cytometry on human samples (fig 8a). Nat Commun (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (6OMP31)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 2
Invitrogen CD19 antibody (ThermoFisher, 6OMP31) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2). J Immunol (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD19 antibody (eBioscience, 17-0199-73) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; 1:100; loading ...; fig S5a
In order to discuss cell type accountable for parvovirus B19 DNA tissue persistence, Invitrogen CD19 antibody (Invitrogen, MHCD1910) was used in flow cytometry on human samples at 1:100 (fig S5a). Nat Commun (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2c
Invitrogen CD19 antibody (eBiosciences, HIB19) was used in flow cytometry on human samples (fig 2c). PLoS Pathog (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to identify a role for CK2 in healthy human thymocytes in the selection of the gamma delta T-cell lineage, Invitrogen CD19 antibody (eBioscience, UCHT1) was used . Leukemia (2017) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 2a
In order to discuss the use of natural killer cells for clinical applications, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples (fig 2a). Cytotherapy (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2e
In order to investigate the role of Eomes in the retention of liver natural killer cells, Invitrogen CD19 antibody (eBiosciences, HIB19) was used in flow cytometry on human samples (fig 2e). J Immunol (2016) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, Invitrogen CD19 antibody (Thermo Scientific, SJ25-C1) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen CD19 antibody (Invitrogen, UCHT1) was used . AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s5
Invitrogen CD19 antibody (eBioscience, H1B19) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, Invitrogen CD19 antibody (eBioscience, SJ25C1) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 2
Invitrogen CD19 antibody (eBioscience, 11-0199-41) was used in flow cytometry on human samples (fig 2). Stem Cell Reports (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
Invitrogen CD19 antibody (eBioscience, 48-0199) was used in flow cytometry on human samples (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, Invitrogen CD19 antibody (eBiosciences, HIB19) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to characterize B cells and antibody repertoires from injection drug users, Invitrogen CD19 antibody (Invitrogen, UCHT1) was used . PLoS ONE (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:50; loading ...; fig 1e
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, Invitrogen CD19 antibody (eBiosciences, 12-0199) was used in flow cytometry on human samples at 1:50 (fig 1e). Nat Cell Biol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:200; fig 7
Invitrogen CD19 antibody (eBioscience, 13-0199) was used in flow cytometry on human samples at 1:200 (fig 7). Haematologica (2016) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 4
In order to report the results of the rituximab by intravenous and Intrathecai injection versus placebo in patients with low-inflammatory secondary progressive multiple sclerosis study, Invitrogen CD19 antibody (Life Technologies, SJ25-C1) was used in flow cytometry on human samples (fig 4). Ann Clin Transl Neurol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:50
Invitrogen CD19 antibody (ebioscience, HIB19) was used in flow cytometry on human samples at 1:50. PLoS ONE (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig s1a
In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, Invitrogen CD19 antibody (eBioscience, 1170199-42) was used in flow cytometry on human samples at 1:100 (fig s1a). Acta Neuropathol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1b
In order to test if NR2F2 contributes to the stemness maintenance of mesenchymal stem cells, Invitrogen CD19 antibody (eBioscience, 17-0199) was used in flow cytometry on human samples (fig 1b). Stem Cells Int (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen CD19 antibody (eBioscience, UCHT1) was used . Immunol Res (2016) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to analyze the difference in immune profiles at the pandemic epicenter in two pandemic Influenza A (H1N1) pdm09 virus waves, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 1). Arch Med Res (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 7
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig 7). Eur J Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD19 antibody (eBioscience, H1B19) was used in flow cytometry on mouse samples . Nat Chem Biol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4b
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, Invitrogen CD19 antibody (eBioscience, 56-0199-42) was used in flow cytometry on human samples (fig 4b). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, 25-0199) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 4
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig 4). Leukemia (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig S1
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (fig S1). J Neuroinflammation (2015) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples (fig 1). J Exp Med (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
Invitrogen CD19 antibody (eBioscience, Hib19) was used in flow cytometry on human samples (fig 1). Blood (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to investigate metadherin expression, significance, and related mechanism in chronic lymphocytic leukemia, Invitrogen CD19 antibody (ebioscience, 12-0198) was used in flow cytometry on human samples . Med Oncol (2015) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to test if mesenchymal stromal cells support the growth and survival of leukemic stem cells in vitro, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples . Stem Cell Res (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, 25-0199) was used in flow cytometry on human samples . J Pediatr Surg (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; tbl 3
In order to test if flow cytometry can be used to find mantle cell lymphoma, Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples (tbl 3). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (e-Bioscience, HIB19) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . J Hepatol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to describe a method using polarization diffraction imaging flow cytometry to identify cells without labeling, Invitrogen CD19 antibody (Life Technologies, MHCD1901) was used in flow cytometry on human samples . Cytometry A (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples . Leukemia (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBiosciences, HIB19) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to study NK function in solid tumors, Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, Invitrogen CD19 antibody (Invitrogen, UCHT1) was used . PLoS Pathog (2014) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to examine the function of NK- and T-cells in order to understand how chronic myeloid leukemia patients maintain the treatment response after IFN-alpha discontinuation, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen CD19 antibody (eBioscience, UCHT1) was used . J Infect Dis (2014) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; 1:10; fig 4
In order to investigate the cytotoxicity of acyl glucuronide, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples at 1:10 (fig 4). Drug Metab Dispos (2014) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to study induction by bacillus anthracis peptidoglycan in human blood due to toxin inhibition of antimicrobrial factors, Invitrogen CD19 antibody (Invitrogen, noca) was used in flow cytometry on human samples . Infect Immun (2013) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 9
In order to characterize T cell responses of HIV-exposed, yet persistently uninfected individuals, Invitrogen CD19 antibody (Invitrogen, MHCD1928) was used in flow cytometry on human samples (fig 9). J Virol (2013) ncbi
mouse monoclonal (SJ25-C1)
  • immunocytochemistry; human; fig 1
In order to assess the effect of immunosuppression used for organ transplantation on immune responses to adeno-associated virus capsid antigens, Invitrogen CD19 antibody (Invitrogen, clone SJ25-C1) was used in immunocytochemistry on human samples (fig 1). Hum Gene Ther (2013) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to test if impaired human neonatal CD4(+) T cell immunity is due to reduced signaling by naive CD4(+) T cells following engagement of the alphabeta-TCR/CD3 complex and CD28, Invitrogen CD19 antibody (Invitrogen, clone SJ25-C1) was used in flow cytometry on human samples (fig 1). J Immunol (2013) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to design altered peptide antigens for the selection of superior T-cell clonotypes with enhanced antigen recognition properties, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples . J Biol Chem (2012) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to characterize therapy-induced T cell reactivity using a panel of 145 melanoma-associated CD8(+) T cell epitopes, Invitrogen CD19 antibody (Invitrogen, MHCD1929) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2012) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD19 antibody (eBioscience, HIB19) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to explore the multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, Invitrogen CD19 antibody (Invitrogen, clone SJ25-C1) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 3
In order to discuss how co-infections and secondary parasite infections may disrupt the immunologic responses induced by a pre-existing parasitic infection, Invitrogen CD19 antibody (InVitrogen, SJ25-C1) was used in flow cytometry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; loading ...; fig 2a
In order to investigate leukocyte-endothelial interactions at the blood brain barrier, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples (fig 2a). Sci Transl Med (2012) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 3
In order to assess the response to the pandemic (p)H1N1 vaccine in young and elderly individuals in vivo and in vitro, Invitrogen CD19 antibody (Invitrogen, MHCD1928) was used in flow cytometry on human samples (fig 3). Int Immunol (2012) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; African green monkey; fig 3
In order to investigate the contribution of costimulatory molecules during SIV vaccination, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on African green monkey samples (fig 3). PLoS ONE (2011) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 2
In order to discuss the live attenuated yellow fever vaccines, Invitrogen CD19 antibody (Caltag, ST25-C1) was used in flow cytometry on human samples (fig 2). J Infect Dis (2011) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 8
In order to test if anti-CD8 Abs induce effector function, Invitrogen CD19 antibody (Caltag, clone SJ25-C1) was used in flow cytometry on human samples (fig 8). J Immunol (2011) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to test if rejection of AAV-transduced hepatocytes is due to AAV capsid-specific CD8 positive T cells that become reactivated upon gene transfer, Invitrogen CD19 antibody (Invitrogen, clone SJ25-C1) was used in flow cytometry on human samples (fig 1). Mol Ther (2011) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1, 2
In order to examine the impact of Tregs on CAR-modified T cells in the SCID-Beige xenotransplant model, Invitrogen CD19 antibody (Caltag, SJ25-C) was used in flow cytometry on human samples (fig 1, 2). Cancer Res (2011) ncbi
mouse monoclonal (SJ25-C1)
  • immunocytochemistry; human
In order to discuss the use of internal antigens to provide better protection against multiple influenza subtypes, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in immunocytochemistry on human samples . Clin Infect Dis (2011) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to test if CD27(+) B cells are susceptible to apoptosis when infected with hepatitis C virus, Invitrogen CD19 antibody (Invitrogen, MHCD1905) was used in flow cytometry on human samples (fig 1). Virus Res (2011) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to find cell surface markers that discriminate CLL-type MBL from CLL, Invitrogen CD19 antibody (Caltag, MHCD1918) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2010) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to elucidate the effects of chronic hepatitis C virus infection on B-cell dynamics, Invitrogen CD19 antibody (Invitrogen, MHCD1905) was used in flow cytometry on human samples (fig 1). J Interferon Cytokine Res (2010) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to discuss the benefits of studying primary immunodeficiencies, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 1). Int Arch Allergy Immunol (2010) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to describe protocols for immunostaining and multiparameter flow cytometric analysis of major human antigen-presenting cells in peripheral blood, Invitrogen CD19 antibody (Invitrogen, MHCD1929) was used in flow cytometry on human samples . Nat Protoc (2010) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
In order to study IL-7 receptor expression and IL-7 signaling in human thymocytes, Invitrogen CD19 antibody (eBioscience, H1B19) was used in flow cytometry on human samples (fig 1). Hum Immunol (2010) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 3
In order to generate biologically active recombinant human Flt3 ligand from transgenic barley seeds, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on human samples (fig 3). Biotechnol J (2010) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to review the roles of B cell subsets during chronic hepatitis C virus infection, Invitrogen CD19 antibody (Invitrogen, MHCD1905) was used in flow cytometry on human samples (fig 1). Biochem Biophys Res Commun (2009) ncbi
mouse monoclonal (SJ25-C1)
In order to elucidate factors involved in myeloid dendritic cell differentiation, Invitrogen CD19 antibody (Caltag, FJ25-C1) was used . Blood (2009) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; 1:20; fig 3
In order to investigate targeting CEACAM6 for treatment of pancreatic adenocarcinomas, Invitrogen CD19 antibody (CalTag, clone MHCD1904) was used in flow cytometry on human samples at 1:20 (fig 3). J Pathol (2009) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; rhesus macaque
In order to discuss the effects of in vivo CTLA-4 blockade as a part of a DNA vaccination regimen in cynomolgus macaques, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on rhesus macaque samples . J Med Primatol (2008) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 2a
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 2a). Nat Protoc (2008) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to develop a 6-color assay to identify dendritic cells, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2008) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; rhesus macaque
  • flow cytometry; crab eating macaque
In order to assess PD-1 expression on CD3 positive T cells after DNA vaccination or lentiviral infection of macaques, Invitrogen CD19 antibody (Invitrogen, SJ25-C1) was used in flow cytometry on rhesus macaque samples and in flow cytometry on crab eating macaque samples . Eur J Immunol (2008) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; fig 4
In order to assess the immunological status after Bz-treatment during early indeterminate Chagas disease, Invitrogen CD19 antibody (Caltag, 4G7) was used in flow cytometry on human samples (fig 4). Microbes Infect (2008) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; fig 1
In order to characterize the kinetics of the adaptive immune response following primary 17DD vaccination in order to clarify how it elicits such broad protection, Invitrogen CD19 antibody (Caltag, 4G7) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2007) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to characterize CD34+ cells from bone marrow of untreated patients with chronic myelogenous leukemia in chronic phase, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples . Leukemia (2007) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to examine loss of CD20 in chronic lymphocytic leukemia, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to characterize a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma called LAGlambda-1, Invitrogen CD19 antibody (CALTAG, SJ25-C1) was used in flow cytometry on human samples . Int J Oncol (2006) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; tbl 1
In order to assess the capacity of cord blood stem cells to repopulate irradiated NOD/SCID mice after cryopreservation, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (tbl 1). Haematologica (2006) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 4
In order to test if delta-1 affects the formation of human plasmacytoid dendritic cells, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 4). Blood (2006) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to discuss methods to distinguish natural killer cells from natural killer T cells, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples . Cytometry A (2005) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; tbl 1
In order to evaluate the diagnostic value of CD123 expression in B-cell disorders with circulating hairy and villous lymphocytes, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (tbl 1). Haematologica (2004) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; tbl 1
In order to test if adiponectin affects lymphohematopoiesis, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (tbl 1). J Immunol (2003) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to investigate the trafficking patterns of leukocytes between the systemic circulation and the noninflamed central nervous system, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2003) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; 5 ug/ml
In order to characterize human splenic dendritic cells, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples at 5 ug/ml. Blood (2001) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 4
In order to compare the immune responses of T cells isolated from human secondary lymphoid organs and peripheral blood, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 4). Int Immunol (2001) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 2
In order to characterize the localization and function of STRL33/Bonzo, Invitrogen CD19 antibody (Caltag, SJ35-C1) was used in flow cytometry on human samples (fig 2). Blood (2000) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to study the role of CD28/CTLA-4/B7 signaling in liver rejection, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 1). Hum Immunol (2000) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 1
In order to elucidate the relationship between aberrant marker expression and DNA ploidy in patients with acute leukemia, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 1). Leuk Lymphoma (1999) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
In order to investigate if expression of CD79b, CD5, and CD19 can be used to diagnose B-cell disorders, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples . Haematologica (1999) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human; fig 2
In order to compare the expression pattern of CD13, CD33, and CD117 in patients with acute myelogenous leukemia, Invitrogen CD19 antibody (Caltag, SJ25-C1) was used in flow cytometry on human samples (fig 2). Leuk Res (1999) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human
In order to assess the effects of the FLK-2/FLT-3 ligand on the growth of human fetal liver progenitors, Invitrogen CD19 antibody (Caltag, 4G7) was used in flow cytometry on human samples . Blood (1995) ncbi
Abcam
domestic rabbit polyclonal
  • immunocytochemistry; mouse; loading ...; fig 2a
Abcam CD19 antibody (Abcam, ab203615) was used in immunocytochemistry on mouse samples (fig 2a). Clin Transl Med (2022) ncbi
domestic rabbit monoclonal (EPR5906)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 4e
Abcam CD19 antibody (Abcam, ab134114) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 4e). EBioMedicine (2022) ncbi
domestic rabbit monoclonal (EPR5906)
  • immunohistochemistry; human; 1:50; fig 2e
Abcam CD19 antibody (Abcam, ab134114) was used in immunohistochemistry on human samples at 1:50 (fig 2e). Front Immunol (2021) ncbi
domestic rabbit monoclonal (EPR5906)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1c
Abcam CD19 antibody (Abcam, ab134114) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1c). Nat Commun (2019) ncbi
mouse monoclonal (CB19)
  • flow cytometry; human; 1:100; loading ...; fig S5a
In order to discuss cell type accountable for parvovirus B19 DNA tissue persistence, Abcam CD19 antibody (Abcam, ab1168) was used in flow cytometry on human samples at 1:100 (fig S5a). Nat Commun (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 1b
In order to explore the contribution of CD105 to leukemogenesis, Abcam CD19 antibody (Abcam, SJ25-C1) was used in flow cytometry on human samples (fig 1b). Blood (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig s4b
Abcam CD19 antibody (Abcam, SJ25-C1) was used in flow cytometry on human samples (fig s4b). J Immunol (2016) ncbi
domestic rabbit monoclonal (EPR5906)
  • immunohistochemistry - frozen section; human; fig s1a
Abcam CD19 antibody (Abcam, ab134114) was used in immunohistochemistry - frozen section on human samples (fig s1a). Arthritis Res Ther (2016) ncbi
Miltenyi Biotec
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; fig s2a
Miltenyi Biotec CD19 antibody (Miltenyi Biotec, 130-113-730) was used in flow cytometry on human samples (fig s2a). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; fig 1
Miltenyi Biotec CD19 antibody (Miltenyi, LT19) was used in flow cytometry on human samples (fig 1). BMC Cancer (2019) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; fig 2c
Miltenyi Biotec CD19 antibody (Miltenyi Biotech, LT19) was used in flow cytometry on human samples (fig 2c). Sci Rep (2018) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; fig s7a
Miltenyi Biotec CD19 antibody (Miltenyi, LT19) was used in flow cytometry on human samples (fig s7a). Front Immunol (2017) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, Miltenyi Biotec CD19 antibody (Miltenyi Biotec, LT19) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; fig 4b
Miltenyi Biotec CD19 antibody (Miltenyi Biotec, LT19) was used in flow cytometry on human samples (fig 4b). Front Immunol (2017) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; fig 1b
In order to develop a robust in vitro model to study chronic lymphocytic leukemia B cell receptor ligation, Miltenyi Biotec CD19 antibody (Miltenyi Biotec, LT19) was used in flow cytometry on human samples (fig 1b). Br J Cancer (2016) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; loading ...; tbl 1
In order to discuss cell- and tissue-specific changes in DNA methylation in type 1 diabetes, Miltenyi Biotec CD19 antibody (Miltenyi Biotec, LT19) was used in flow cytometry on human samples (tbl 1). Methods Mol Biol (2016) ncbi
Bio-Rad
mouse monoclonal (LT19)
  • flow cytometry; human; 1:10; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, Bio-Rad CD19 antibody (Bio-Rad, LT19) was used in flow cytometry on human samples at 1:10 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (SJ25-C1)
  • flow cytometry; human
Bio-Rad CD19 antibody (AbD Serotec, SJ25-C1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (LE-CD19)
  • immunohistochemistry - paraffin section; human
Bio-Rad CD19 antibody (Serotec, MCA2454) was used in immunohistochemistry - paraffin section on human samples . Leuk Lymphoma (2014) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human; fig 1
Bio-Rad CD19 antibody (ABD Serotec, MCA1940A488) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (LT19)
  • flow cytometry; human
Bio-Rad CD19 antibody (AbD Serotec, MCA1940F) was used in flow cytometry on human samples . MAbs (2012) ncbi
Santa Cruz Biotechnology
mouse monoclonal (SJ25C1)
  • mass cytometry; human; loading ...; fig s1
Santa Cruz Biotechnology CD19 antibody (Santa Cruz, SJ25C1) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (HD37)
  • flow cytometry; human; loading ...; fig s1c
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, Santa Cruz Biotechnology CD19 antibody (Santa Cruz, HD37) was used in flow cytometry on human samples (fig s1c). Cell Rep (2016) ncbi
mouse monoclonal (HD37)
  • immunocytochemistry; human
Santa Cruz Biotechnology CD19 antibody (Santa Cruz Biotechnology, HD37) was used in immunocytochemistry on human samples . J Cell Physiol (2014) ncbi
Absolute Antibody
mouse monoclonal (FMC63)
  • flow cytometry; brewer's yeast; loading ...; fig 2a
Absolute Antibody CD19 antibody (Absolute Antibody, FMC63) was used in flow cytometry on brewer's yeast samples (fig 2a). ACS Synth Biol (2021) ncbi
OriGene
mouse monoclonal (OTI2F6)
  • immunocytochemistry; mouse; loading ...; fig 1b
OriGene CD19 antibody (OriGene, TA506240) was used in immunocytochemistry on mouse samples (fig 1b). elife (2018) ncbi
Beckman Coulter
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...
Beckman Coulter CD19 antibody (Beckman Coulter, IM2708U) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig s2). EBioMedicine (2020) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig s4a
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig s4a). Nat Commun (2020) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; 1:40; loading ...; fig s10b
Beckman Coulter CD19 antibody (Beckman Coulter, IM2708U) was used in flow cytometry on human samples at 1:40 (fig s10b). Science (2019) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig s18
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig s18). J Clin Invest (2019) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig 4a
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig 4a). J Clin Invest (2018) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig s3f
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig s3f). J Clin Invest (2017) ncbi
mouse monoclonal (HD237)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD19 antibody (Beckman Coulter, 6604551) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, Beckman Coulter CD19 antibody (Beckman Coulter, IM3628) was used in flow cytometry on human samples (tbl 2). J Immunol Methods (2017) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig 2c
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig 2c). Clin Immunol (2017) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; 1:25; fig 4
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples at 1:25 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; fig 1a
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig 1a). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter CD19 antibody (Beckman-Coulter, J3.119) was used in flow cytometry on human samples (fig 2a). Sci Rep (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; fig s3c
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig s3c). Science (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; fig s2
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (fig s2). Sci Rep (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; rhesus macaque; 1:30
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, Beckman Coulter CD19 antibody (Beckman Coulter, IM2643U) was used in flow cytometry on rhesus macaque samples at 1:30. Nat Med (2016) ncbi
mouse monoclonal (J3-119)
  • other; human; 200 ug/ml; fig 2
Beckman Coulter CD19 antibody (Beckman Coulter, IM1313) was used in other on human samples at 200 ug/ml (fig 2). J Extracell Vesicles (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; tbl 1
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (tbl 1). Int J Lab Hematol (2016) ncbi
mouse monoclonal (J3-119)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; African green monkey; fig 4
In order to study lymph node-resident simian immunodeficiency virus env-specific T follicular helper cells due to vaccine induction in Rhesus Macaques, Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on African green monkey samples (fig 4). J Immunol (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Beckman Coulter CD19 antibody (Beckman Coulter, J3.119) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human
Beckman Coulter CD19 antibody (Beckman-Coulter, J3-119) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), Beckman Coulter CD19 antibody (Beckman-Coulter, J3-119) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; rhesus macaque
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on rhesus macaque samples . Clin Immunol (2014) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human
Beckman Coulter CD19 antibody (Beckman Coulter, J3-119) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (J3-119)
  • flow cytometry; human; fig 2
Beckman Coulter CD19 antibody (Beckman Coulter, IM3628U) was used in flow cytometry on human samples (fig 2). Cytometry B Clin Cytom (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5f
Cell Signaling Technology CD19 antibody (Cell Signaling, 90176) was used in immunohistochemistry - paraffin section on mouse samples (fig 5f). Aging (Albany NY) (2022) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1g
Cell Signaling Technology CD19 antibody (Cell Signaling, D4V4B) was used in immunohistochemistry - paraffin section on mouse samples (fig 1g). Front Immunol (2021) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3
Cell Signaling Technology CD19 antibody (Cell Signaling Technologies, D4V4B) was used in immunohistochemistry on mouse samples at 1:500 (fig 3). Mol Psychiatry (2021) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry; mouse; loading ...; fig s4a
Cell Signaling Technology CD19 antibody (Cell Signaling, 90176) was used in immunohistochemistry on mouse samples (fig s4a). Cells (2021) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry - paraffin section; mouse; 1:600; loading ...; fig 2e
Cell Signaling Technology CD19 antibody (CST, 90176) was used in immunohistochemistry - paraffin section on mouse samples at 1:600 (fig 2e). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry; mouse; loading ...; fig 3
Cell Signaling Technology CD19 antibody (Cell Signaling Technology, D4V4B) was used in immunohistochemistry on mouse samples (fig 3). PLoS ONE (2021) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4
Cell Signaling Technology CD19 antibody (Cell Signaling Technology, D4V4B) was used in immunohistochemistry - paraffin section on mouse samples (fig s4). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 4d
Cell Signaling Technology CD19 antibody (Cell Signaling, 3574S) was used in western blot on human samples at 1:500 (fig 4d). elife (2020) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e8d
Cell Signaling Technology CD19 antibody (Cell Signaling, 90176) was used in immunohistochemistry - paraffin section on mouse samples (fig e8d). Nature (2019) ncbi
domestic rabbit monoclonal (D4V4B)
  • immunohistochemistry; mouse; loading ...; fig 2j
Cell Signaling Technology CD19 antibody (Cell Signaling, D4V4B) was used in immunohistochemistry on mouse samples (fig 2j). J Immunol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology CD19 antibody (Cell Signaling, 3574) was used in western blot on human samples (fig 2d). Mol Cell Biol (2018) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:400; fig 1c
In order to elucidate how hepatitis C virus infection alters B cell proliferation, Cell Signaling Technology CD19 antibody (Cell Signaling Technology, 3574) was used in immunocytochemistry on human samples at 1:400 (fig 1c). Oncogene (2016) ncbi
Dako
mouse monoclonal (LE-CD19)
  • immunohistochemistry; human; 1:50; fig s1f
Dako CD19 antibody (Dako, LE-CD19, M7296) was used in immunohistochemistry on human samples at 1:50 (fig s1f). Nature (2021) ncbi
mouse monoclonal (LE-CD19)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4b
In order to describe the evolution of ibrutinib resistance using samples from five patients with chronic lymphocytic leukemia, Dako CD19 antibody (Dako, LE-CD19) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4b). Nat Commun (2016) ncbi
mouse monoclonal (LE-CD19)
  • immunohistochemistry - paraffin section; human; 1:500; fig 2
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, Dako CD19 antibody (Dako, LE-CD19) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2). J Immunol (2016) ncbi
BD Biosciences
mouse monoclonal (SJ25C1)
  • flow cytometry; human; 1:100; loading ...; fig 1b
BD Biosciences CD19 antibody (BD Pharmingen, 557791) was used in flow cytometry on human samples at 1:100 (fig 1b). Nat Commun (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s1
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig s1). Mol Ther Methods Clin Dev (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2e
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 2e). Med Oncol (2022) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD Pharmingen, 555415) was used in flow cytometry on human samples . Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig s2a). Arthritis Res Ther (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:300; loading ...; fig 6a
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples at 1:300 (fig 6a). Nat Commun (2021) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; 1:100; loading ...; fig 6c
BD Biosciences CD19 antibody (BD Biosciences, 347543) was used in flow cytometry on human samples at 1:100 (fig 6c). Nat Commun (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 3c, 3d
BD Biosciences CD19 antibody (BD Bioscience, HIB19) was used in flow cytometry on human samples (fig 3c, 3d). J Immunother Cancer (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD Biosciences, 561743) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, 557791) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, 557791) was used in flow cytometry on human samples . elife (2021) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD19 antibody (BD Biosciences, 340864) was used in flow cytometry on human samples (fig s1b). Cell (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig 1b). Acta Neuropathol (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD19 antibody (BD Biosciences, 562440) was used in flow cytometry on human samples (fig s1a). Cell (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:200; loading ...; fig s1h
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples at 1:200 (fig s1h). Nature (2021) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD, 4G7) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD19 antibody (Becton Dickinson, 555412) was used in flow cytometry on human samples (fig 1b). Sci Rep (2021) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD19 antibody (BD, 563038) was used in flow cytometry on human samples (fig s2a). Cell (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD19 antibody (BD, 555412) was used in flow cytometry on human samples (fig s2a). Cell (2021) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s1). elife (2020) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig s1). Front Immunol (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD19 antibody (Becton Dickinson, 561121) was used in flow cytometry on human samples (fig s2). Cell (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:500; loading ...; fig 1c
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples at 1:500 (fig 1c). Blood (2020) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD, 4G7) was used in flow cytometry on human samples . J Exp Med (2020) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BD Biosciences CD19 antibody (BD Biosciences, 4G7) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD19 antibody (BD Biosciences, 557921) was used in flow cytometry on human samples (fig 1b). Cell (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (BD Bioscience, HIB19) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; mouse; loading ...; fig s2e
BD Biosciences CD19 antibody (BD, SJ25C1;563038) was used in flow cytometry on mouse samples (fig s2e). Sci Immunol (2020) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 2e
BD Biosciences CD19 antibody (BD Bioscience, HIB19) was used in flow cytometry on human samples (fig 2e). Nat Commun (2020) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD, 340437) was used in flow cytometry on human samples (fig 1). J Cancer (2020) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...; fig s6c
BD Biosciences CD19 antibody (BD, 4G7) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s10b
BD Biosciences CD19 antibody (BD Biosciences, 563036) was used in flow cytometry on human samples (fig s10b). Nat Commun (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; 1:80; loading ...; fig 5k, s22c
BD Biosciences CD19 antibody (BD Biosciences, 557835) was used in flow cytometry on human samples at 1:80 (fig 5k, s22c). Nat Commun (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1a, 1d
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig 1a, 1d). Front Immunol (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig 2c
BD Biosciences CD19 antibody (BD Horizon, 561121) was used in flow cytometry on human samples at 1:100 (fig 2c). elife (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD19 antibody (BD, 561743) was used in flow cytometry on human samples (tbl 1). J Exp Med (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 5e
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig 5e). Nat Med (2019) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s7a
BD Biosciences CD19 antibody (BD Biosciences, 555415) was used in flow cytometry on human samples (fig s7a). Mol Cell (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 9a
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 9a). Front Pharmacol (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig s1). Front Immunol (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD19 antibody (BD Biosciences, 562653) was used in flow cytometry on human samples (fig 3c). BMC Immunol (2019) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s3b
BD Biosciences CD19 antibody (BD Biosciences, 563036) was used in flow cytometry on human samples (fig s3b). Nat Immunol (2018) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD19 antibody (BD, 563325) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...; fig s2a
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on mouse samples (fig s2a). Eur J Immunol (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s7b
BD Biosciences CD19 antibody (BD, 555412) was used in flow cytometry on human samples (fig s7b). Eur J Immunol (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD19 antibody (BD Biosciences, 560994) was used in flow cytometry on human samples (fig 3a). Stem Cell Reports (2018) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig s5
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig s5). J Clin Invest (2018) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD19 antibody (BD Bioscience, 557835) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig s4a). J Clin Invest (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD19 antibody (BD Biosciences, 555412) was used in flow cytometry on human samples (fig 2a). J Virol (2018) ncbi
mouse monoclonal (HIB19)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1b
BD Biosciences CD19 antibody (BD Biosciences, 555409) was used in immunohistochemistry - paraffin section on human samples (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD19 antibody (BD Biosciences, 557791) was used in flow cytometry on human samples (fig s1). Front Immunol (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; fig 1i
BD Biosciences CD19 antibody (BD Biosciences, 555413) was used in flow cytometry on mouse samples (fig 1i). Cell (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 2a). Cancer Immunol Res (2018) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on mouse samples (fig 4a). Mucosal Immunol (2018) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD19 antibody (BD Biosciences, 4G7) was used in flow cytometry on human samples (fig 1d). Nature (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD19 antibody (BD, 560728) was used in flow cytometry on human samples (fig st1). J Exp Med (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s7f
BD Biosciences CD19 antibody (BD Biosciences, 555415) was used in flow cytometry on human samples (fig s7f). Cell (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 4a). J Immunol (2018) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig 2b). Nat Med (2018) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1a
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 1a). Front Immunol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences CD19 antibody (BD Biosciences, 555413) was used in flow cytometry on mouse samples (fig 3b). Cell Stem Cell (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:10; fig s2
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples at 1:10 (fig s2). Nat Commun (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; 1:200; loading ...; fig 2a
BD Biosciences CD19 antibody (BD Biosciences, 560177) was used in flow cytometry on human samples at 1:200 (fig 2a). PLoS ONE (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; fig 4a
In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples at 1:100 (fig 4a). Front Immunol (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, BD Biosciences CD19 antibody (BD Bioscience, SJ25C1) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig 1c). Nature (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig st1). J Exp Med (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 3g
In order to map the lineage of human dendritic cells, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 3g). Science (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . MBio (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD19 antibody (BD Pharmingen, 555415) was used in flow cytometry on human samples (fig s2). Scand J Immunol (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 1b
BD Biosciences CD19 antibody (BD Pharmingen, 340721) was used in flow cytometry on human samples (fig 1b). Scand J Immunol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BD Biosciences CD19 antibody (BD Pharmingen, HIB19) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD19 antibody (BD Bioscience, 562441) was used in flow cytometry on human samples (fig 1a). F1000Res (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD19 antibody (BD, 557835) was used in flow cytometry on human samples (fig 5c). Blood (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences CD19 antibody (BD Biosciences, 555413) was used in flow cytometry on human samples (fig 6a). Mol Ther Methods Clin Dev (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 6b
BD Biosciences CD19 antibody (BD Biosciences, 340364) was used in flow cytometry on human samples (fig 6b). Mol Ther Methods Clin Dev (2017) ncbi
  • flow cytometry; human; loading ...; tbl 1
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, BD Biosciences CD19 antibody (BD, 341109) was used in flow cytometry on human samples (tbl 1). J Immunol Methods (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; mouse; loading ...; fig s4
BD Biosciences CD19 antibody (BD Biosciences, 340951) was used in flow cytometry on mouse samples (fig s4). Nat Commun (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2c
BD Biosciences CD19 antibody (BD, 555413) was used in flow cytometry on human samples (fig s2c). Cell (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig S1a
BD Biosciences CD19 antibody (BD, 555412) was used in flow cytometry on human samples (fig S1a). Sci Rep (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 6
BD Biosciences CD19 antibody (BD Biosciences, 555412) was used in flow cytometry on human samples (fig 6). Sci Rep (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...
BD Biosciences CD19 antibody (Pharmingen, SJ25C1) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD19 antibody (BD Bioscience, HIB19) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD19 antibody (BD Bioscience, SJ25C1) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 4a
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD19 antibody (BD Bioscience, 562441) was used in flow cytometry on human samples (fig 4a). Sci Rep (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 2c
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 2c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . J Immunol Res (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 4b
BD Biosciences CD19 antibody (BD Biosciences, 557791) was used in flow cytometry on human samples (fig 4b). PLoS ONE (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:25; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples at 1:25 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 2c
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 2c). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; 1:100; fig s1c
BD Biosciences CD19 antibody (BD, 349209) was used in flow cytometry on human samples at 1:100 (fig s1c). Nature (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s12a
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s12a). J Clin Invest (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig e6b
In order to report preclinical studies using a CRISPR-based methodology to target hematopoietic stem cells to treat beta-haemoglobinopathies, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig e6b). Nature (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; tbl 3
In order to optimize a method to generate granulocyte lineage-committed progenitors from umbilical cord blood samples, BD Biosciences CD19 antibody (Becton Dickinson, HIB19) was used in flow cytometry on human samples (tbl 3). N Biotechnol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to screen to find antibodies that block HIV-1 acquisition and replication, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . J Virol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . Mucosal Immunol (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a, s2e
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD19 antibody (BD Biosciences, 555415) was used in flow cytometry on human samples (fig 1a, s2e). JCI Insight (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1a, s2e
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD19 antibody (BD Biosciences, 557835) was used in flow cytometry on human samples (fig 1a, s2e). JCI Insight (2016) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...
In order to assess receptor for hyaluronic acid-mediated motility specific dendritic cell responses, BD Biosciences CD19 antibody (BD Biosciences, 345776) was used in flow cytometry on human samples . Oncotarget (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD19 antibody (BD Biosciences, 641395) was used in flow cytometry on human samples (fig st1). PLoS ONE (2016) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD19 antibody (BD, 4G7) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 3
BD Biosciences CD19 antibody (BD PharMingen, 561742) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 3d
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, BD Biosciences CD19 antibody (BD Biosciences, 555415) was used in flow cytometry on human samples (fig 3d). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1
In order to identify cells that respond to interferon lambda, BD Biosciences CD19 antibody (BD Bioscience, SJ25C1) was used in flow cytometry on human samples (fig 1). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig 1a). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s1b
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig s1b). Sci Rep (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD Biosciences, 340719) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...; fig s1c
In order to use flow cytometry and barcoded peptide-major histocompatibility complex multimers to screen for T cell specificities, BD Biosciences CD19 antibody (BD, 345776) was used in flow cytometry on human samples (fig s1c). Nat Biotechnol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD19 antibody (Becton Dickinson, HIB19) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to optimize the generation of therapeutic extracellular vesicles and identify molecules involved in their clearance, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . Biomaterials (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD19 antibody (BD Pharmingen, HIB19) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 1a
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 1a). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD19 antibody (BD Pharmingen, HIB19) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 4a
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 3
In order to test if CD4 positive T cells expressing immune checkpoint molecules are enriched in HIV-infected cells in patients receiving antiretroviral therapy, BD Biosciences CD19 antibody (BD, 339190) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 2a
In order to assess the inflammatory responses in the rectal mucosa of patients with well-defined non-celiac wheat sensitivity, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 2a). Clin Transl Gastroenterol (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize B cells and antibody repertoires from injection drug users, BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences CD19 antibody (BD Biosciences, 561121) was used in flow cytometry on human samples . Nat Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 3d
In order to study the function of desmoglein-2 and generate knockout mice, BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig 3d). Angiogenesis (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD19 antibody (BD Pharmingen, SJ25C1) was used in flow cytometry on human samples (fig 3b). J Clin Invest (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:25; fig 1b
In order to develop and characterize a humanized ossicle xenotransplantation approach, BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples at 1:25 (fig 1b). Nat Med (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:200; loading ...; fig 7f
In order to find that coagulation factor XII modulates immune responses, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples at 1:200 (fig 7f). Nat Commun (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 2
In order to utilize flow cytometry to analyze intracellular Ca(2+) mobilization in human NK cell subsets, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s2a
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s2a). PLoS ONE (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 2
BD Biosciences CD19 antibody (BD, HIB-19) was used in flow cytometry on human samples (fig 2). JCI Insight (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:80; fig 3
BD Biosciences CD19 antibody (BD PharMingen, 561121) was used in flow cytometry on human samples at 1:80 (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; loading ...
In order to explore the contribution of Musashi-2 in determining hematopoietic stem cell fate, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on mouse samples . Nature (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s3). PLoS ONE (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig 1e). Cancer Med (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s2
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig s2). Eur J Immunol (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s4
In order to assess the effects of lenalidomide on normal human plasma cell generation, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s4). Oncotarget (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1b
In order to study the effect of germline-targeting immunogen on HIV-1 broadly neutralizing antibody precursor B cells, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s1b). Science (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD19 antibody (BD, 555413) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1b
In order to characterize B and T cells from patients with thrombocytopenia, BD Biosciences CD19 antibody (BD Biosciences, 557791) was used in flow cytometry on human samples (fig 1b). Haematologica (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to describe a method to expand antigen-specific regulatory T cells in vivo, BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples . Nature (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences CD19 antibody (Becton Dickinson, 560911) was used in flow cytometry on human samples (fig 6a). BMC Biotechnol (2016) ncbi
mouse monoclonal (HIB19)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences CD19 antibody (BD, HIB19) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Pharmingen, 341113) was used in flow cytometry on human samples . Nature (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; tbl 2
In order to measure the expression of antigens on malignant human plasma cells that have exhibited promise in targeted cancer therapy, BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 2e
In order to elucidate the role of TfR1 in adaptive immunity, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 2e). Nat Genet (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD Biosciences, 555413) was used in flow cytometry on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4b
In order to study heat-shock protein 70 in non-small cell lung cancer cells, BD Biosciences CD19 antibody (BD, 555413) was used in flow cytometry on human samples (fig 4b). Front Immunol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; tbl 1
In order to determine support for heparin-free mesenchymal stem cell propagation in human platelet lysate by mechanical fibrinogen-depletion, BD Biosciences CD19 antibody (Becton Dickinson, SJ25C1) was used in flow cytometry on human samples (tbl 1). J Transl Med (2015) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize oligopotent progenitors from the fetal liver, BD Biosciences CD19 antibody (BD, 349209) was used in flow cytometry on human samples (fig 4a). Science (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig s1a, 4a, s1c
In order to characterize oligopotent progenitors from the fetal liver, BD Biosciences CD19 antibody (BD, 340364) was used in flow cytometry on human samples (fig s1a, 4a, s1c). Science (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 3a
In order to discover that CD147-CD98 is a major carrier of poly-N-acetyl-lactosamine on human pre-B cell line, BD Biosciences CD19 antibody (BD Pharmingen, 555415) was used in flow cytometry on human samples (fig 3a). J Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 2
BD Biosciences CD19 antibody (BD Biosciences, 561295) was used in flow cytometry on human samples (fig 2). MAbs (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to assess the role of B cells in tolerant kidney transplant recipients, BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples . Am J Transplant (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
In order to study B cells migration in vivo, BD Biosciences CD19 antibody (BD Biosciences, 555415) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s4
BD Biosciences CD19 antibody (BD Biosciences, 555411) was used in flow cytometry on human samples (fig s4). Nature (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 3b
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences CD19 antibody (BD PharMingen, HIB19) was used in flow cytometry on human samples (fig 3b). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 3a
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 3a). PLoS Negl Trop Dis (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, 340437) was used in flow cytometry on human samples . Leukemia (2016) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples . J Immunol Res (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the effect of miRNA-155 in IL-21 signaling in white cells and it role in systemic lupues erythematosus., BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 4a
BD Biosciences CD19 antibody (BD Biosciences, 557835) was used in flow cytometry on human samples (fig 4a). Mol Ther Methods Clin Dev (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD Bioscience, 555413) was used in flow cytometry on human samples (fig 1). J Hematol Oncol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 2a). Ann Rheum Dis (2016) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, 340951) was used in flow cytometry on human samples . J Exp Med (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 5
In order to examine the antibody repertoire of patients with acute systemic lupus erythematosus, BD Biosciences CD19 antibody (BD Pharmingen, SJ25C1) was used in flow cytometry on human samples (fig 5). Nat Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100; fig s10a
In order to analyze proliferation and homing of multiple myeloma cells promoted by the cyclophilin A-CD147 complex, BD Biosciences CD19 antibody (Becton Dickinson, HIB19) was used in flow cytometry on human samples at 1:100 (fig s10a). Nat Med (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; 1:100; fig s3
BD Biosciences CD19 antibody (BD, 560177) was used in flow cytometry on human samples at 1:100 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human
BD Biosciences CD19 antibody (Becton-Dickinson, 4G7) was used in flow cytometry on human samples . Histochem Cell Biol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Pharmingen, #555415) was used in flow cytometry on human samples . Immunol Invest (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BD Biosciences CD19 antibody (BD Bioscience, Sj25C1) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, 555412) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Pharmingen, 555415) was used in flow cytometry on human samples . Arthritis Res Ther (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, 555413) was used in flow cytometry on human samples . Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples . Nature (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to discuss the use of stem cells to treat Wiskott-Aldrich syndrome, BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1e
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 1e). J Immunol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 1). Int Immunol (2015) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human
In order to describe procedures to establish and maintain primary acute lymphoblastic leukemia xenograft panels, BD Biosciences CD19 antibody (Becton Dickinson, 349209) was used in flow cytometry on human samples . Curr Protoc Pharmacol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to discuss the role of CD47 modulation in treatment of chronic lymphocytic leukemia, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples . PLoS Med (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; tbl 2
BD Biosciences CD19 antibody (BD Bioscience, 4G7) was used in flow cytometry on human samples (tbl 2). Clin Transplant (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Pharmingen, SJ25C1) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Pharmingen, 555412) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (Becton Dickinson, SJ25C1) was used in flow cytometry on human samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; 1:100
In order to compared leukocyte proportions and absolute counts using reference real-time methods with a novel assay that allows long-term cryopreservation of fixed leukocytes for later counting, BD Biosciences CD19 antibody (BD, 557835) was used in flow cytometry on human samples at 1:100. Cytometry A (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to compared leukocyte proportions and absolute counts using reference real-time methods with a novel assay that allows long-term cryopreservation of fixed leukocytes for later counting, BD Biosciences CD19 antibody (BD, 560353) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 5
In order to use of a myoblasts from a symptomatic female carrier of X-linnked Emery-Dreifuss muscular dystrophy to study abnormal proliferation and spontaneous differentiation, BD Biosciences CD19 antibody (Becton Dickinson, 555413) was used in flow cytometry on human samples (fig 5). Neuromuscul Disord (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 2
BD Biosciences CD19 antibody (BD Biosciences, 557921) was used in flow cytometry on human samples (fig 2). PLoS ONE (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 1). J Leukoc Biol (2015) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD PharMingen, SJ25C1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (4G7)
  • flow cytometry; human; fig s3
BD Biosciences CD19 antibody (Becton Dickinson, 4G7) was used in flow cytometry on human samples (fig s3). Blood (2015) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HIB19)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; 5 ul/test
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples at 5 ul/test. Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, SJ25C1) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig 1
In order to characterize VLA-4 blockade and promotion of differential routes into human CNS involving MCAM-adhesion of TH17 cells and PSGL-1 rolling of T cells, BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples (fig 1). J Exp Med (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, BD Biosciences CD19 antibody (BD Bioscience, HIB19) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples . Am J Transplant (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; loading ...; fig 4a
In order to test if proteasome-inhibition complements the effects of corticosteroids to improve outcomes in chronic graft-versus-host disease, BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in flow cytometry on human samples (fig 4a). Biol Blood Marrow Transplant (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to examine various DC after flu vaccination, BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; 1:100
BD Biosciences CD19 antibody (BD Biosciences, 555413) was used in flow cytometry on human samples at 1:100. J Immunol (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BD Biosciences CD19 antibody (BD Bioscience, SJ25C1) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BD Biosciences CD19 antibody (BD Bioscience, HIB19) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Bioscience, HIB19) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (Becton Dickinson, SJ25C1) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Bioscience, 555415) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human; fig s5
BD Biosciences CD19 antibody (BD Biosciences, 555412) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD19 antibody (Becton Dickinson, SJ25C1) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples . Immunology (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; fig 1
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD Biosciences, SJ25C1) was used in flow cytometry on human samples . J Allergy Clin Immunol (2014) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, 561031) was used in flow cytometry on human samples . Part Part Syst Charact (2013) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; mouse; 1:100
  • flow cytometry; human; 1:100
BD Biosciences CD19 antibody (BD Biosciences, 555412) was used in flow cytometry on mouse samples at 1:100 and in flow cytometry on human samples at 1:100. Nat Med (2013) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, BD Biosciences CD19 antibody (BD, clone SJ25C1) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (HIB19)
  • ELISA; human
BD Biosciences CD19 antibody (BD Biosciences, HIB19) was used in ELISA on human samples . J Transl Med (2013) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
In order to discuss the use of PPR ligands as adjuvants and the use of interferon-gamma release assays as a diagnostic tool, BD Biosciences CD19 antibody (BD, 560177) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to discuss the use of PPR ligands as adjuvants and the use of interferon-gamma release assays as a diagnostic tool, BD Biosciences CD19 antibody (BD, 561295) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (SJ25C1)
  • flow cytometry; human
BD Biosciences CD19 antibody (BD, clone SJ25C1) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to study the use of DEC-205 targeting in vaccination against Epstein-Barr virus, BD Biosciences CD19 antibody (BD, HIB19) was used in flow cytometry on human samples . Blood (2008) ncbi
mouse monoclonal (HIB19)
  • flow cytometry; human
In order to investigate novel monoclonal antibodies to ZAP-70 to detect B-cell chronic lymphocytic leukemia, BD Biosciences CD19 antibody (BD PharMingen, HIB19) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2006) ncbi
Articles Reviewed
  1. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  2. Sullivan P, Kumar R, Li W, Hoglund V, Wang L, Zhang Y, et al. FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma. Mol Cancer Ther. 2022;21:1608-1621 pubmed publisher
  3. Zhu Y, Gu H, Yang L, Li N, Chen Q, Kang D, et al. Involvement of MST1/mTORC1/STAT1 activity in the regulation of B-cell receptor signalling by chemokine receptor 2. Clin Transl Med. 2022;12:e887 pubmed publisher
  4. Ferguson I, Pati xf1 o Escobar B, Tuomivaara S, Lin Y, Nix M, Leung K, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022;13:4121 pubmed publisher
  5. Rosa T, Mendes M, Linhares N, Rodrigues T, Dias A, Leal Calvo T, et al. The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum. Front Med (Lausanne). 2022;9:899998 pubmed publisher
  6. Shankar S, Stolp J, Juvet S, Beckett J, Macklin P, Issa F, et al. Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis. Nat Commun. 2022;13:3121 pubmed publisher
  7. Poletto E, Colella P, Pimentel Vera L, Khan S, Tomatsu S, Baldo G, et al. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022;25:392-409 pubmed publisher
  8. Omari S, Geraghty D, Khalafallah A, Venkat P, Shegog Y, Ragg S, et al. Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies. Med Oncol. 2022;39:81 pubmed publisher
  9. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed publisher
  10. Pascal L, Igarashi T, Mizoguchi S, Chen W, Rigatti L, Madigan C, et al. E-cadherin deficiency promotes prostate macrophage inflammation and bladder overactivity in aged male mice. Aging (Albany NY). 2022;14:2945-2965 pubmed publisher
  11. Wu X, Xia T, Shin W, Yu K, Jung W, Herrmann A, et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. MBio. 2022;13:e0040222 pubmed publisher
  12. Yang J, Zhang Q, Wang J, Lou Y, Hong Z, Wei S, et al. Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy. EBioMedicine. 2022;78:103958 pubmed publisher
  13. Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7:83 pubmed publisher
  14. Elfrink S, ter Beest M, Janssen L, Baltissen M, Jansen P, Kenyon A, et al. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma. Blood Adv. 2022;6:2254-2266 pubmed publisher
  15. Hao W, Luo Q, Menger M, Fassbender K, Liu Y. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase. Front Immunol. 2021;12:792465 pubmed publisher
  16. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  17. Arinrad S, Wilke J, Seelbach A, Doeren J, Hindermann M, Butt U, et al. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance. Mol Psychiatry. 2021;: pubmed publisher
  18. Qian S, Huang Q, Chen R, Mo J, Zhou L, Zhao Y, et al. Single-Cell RNA Sequencing Identifies New Inflammation-Promoting Cell Subsets in Asian Patients With Chronic Periodontitis. Front Immunol. 2021;12:711337 pubmed publisher
  19. Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6:341 pubmed publisher
  20. Reijm S, Kissel T, Stoeken Rijsbergen G, Slot L, Wortel C, van Dooren H, et al. Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load. Arthritis Res Ther. 2021;23:230 pubmed publisher
  21. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  22. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  23. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  24. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  25. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed publisher
  26. Maier J, Rogg M, Helmstädter M, Sammarco A, Walz G, Werner M, et al. A Novel Model for Nephrotic Syndrome Reveals Associated Dysbiosis of the Gut Microbiome and Extramedullary Hematopoiesis. Cells. 2021;10: pubmed publisher
  27. Amanat F, Thapa M, Lei T, Ahmed S, Adelsberg D, Carreño J, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. 2021;184:3936-3948.e10 pubmed publisher
  28. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  29. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed publisher
  30. Ecker V, Stumpf M, Brandmeier L, Neumayer T, Pfeuffer L, Engleitner T, et al. Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. Nat Commun. 2021;12:3526 pubmed publisher
  31. Hibl B, Dailey Garnes N, Kneubehl A, Vogt M, Spencer Clinton J, Rico Hesse R. Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects. PLoS Negl Trop Dis. 2021;15:e0009427 pubmed publisher
  32. Pereira J, Cavaco P, da Silva R, Pacheco Leyva I, Mereiter S, Pinto R, et al. P-selectin glycoprotein ligand 1 promotes T cell lymphoma development and dissemination. Transl Oncol. 2021;14:101125 pubmed publisher
  33. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  34. Ukadike K, Ni K, Wang X, Taylor M, LaCava J, Pachman L, et al. IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus. Arthritis Res Ther. 2021;23:153 pubmed publisher
  35. Marozin S, Simon Nobbe B, Irausek S, Chung L, Lepperdinger G. Kinship of conditionally immortalized cells derived from fetal bone to human bone-derived mesenchymal stroma cells. Sci Rep. 2021;11:10933 pubmed publisher
  36. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  37. Williams W, Meyerhoff R, Edwards R, Li H, Manne K, Nicely N, et al. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021;184:2955-2972.e25 pubmed publisher
  38. Landayan D, Wang B, Zhou J, Wolf F. Thirst interneurons that promote water seeking and limit feeding behavior in Drosophila. elife. 2021;10: pubmed publisher
  39. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  40. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed publisher
  41. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed publisher
  42. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed publisher
  43. Clark S, Clark L, Pan J, Coscia A, McKay L, Shankar S, et al. SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell. 2021;184:2605-2617.e18 pubmed publisher
  44. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  45. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  46. Jeong J, Choi S, Ahn S, Oh J, Kim Y, Lee C, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23:88 pubmed publisher
  47. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  48. Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021;184:1821-1835.e16 pubmed publisher
  49. Khosravi Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612 pubmed publisher
  50. Adam K, Iuga A, Tocheva A, Mor A. A novel mouse model for checkpoint inhibitor-induced adverse events. PLoS ONE. 2021;16:e0246168 pubmed publisher
  51. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  52. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  53. Bullerwell C, Robichaud P, Deprez P, Joy A, Wajnberg G, D Souza D, et al. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex. Sci Rep. 2021;11:1537 pubmed publisher
  54. Susa K, Rawson S, Kruse A, Blacklow S. Cryo-EM structure of the B cell co-receptor CD19 bound to the tetraspanin CD81. Science. 2021;371:300-305 pubmed publisher
  55. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  56. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  57. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed publisher
  58. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  59. Katano I, Ito R, Kawai K, Takahashi T. Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse. Front Immunol. 2020;11:532684 pubmed publisher
  60. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  61. Dhanasekaran R, Park J, Yevtodiyenko A, Bellovin D, Adam S, Kd A, et al. MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC. Mol Ther Nucleic Acids. 2020;21:850-859 pubmed publisher
  62. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  63. Hood S, Cosma G, Foulds G, Johnson C, Reeder S, McArdle S, et al. Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data. elife. 2020;9: pubmed publisher
  64. Kim J, Lee J, Go H, Lim J, Oh J, Kim Y, et al. Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis. Arthritis Res Ther. 2020;22:173 pubmed publisher
  65. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  66. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  67. Seitz V, Kleo K, Dröge A, Schaper S, Elezkurtaj S, Bedjaoui N, et al. Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL. Sci Rep. 2020;10:10024 pubmed publisher
  68. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed publisher
  69. Kuhny M, Forbes L, Çakan E, Vega Loza A, Kostiuk V, Dinesh R, et al. Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID. J Clin Invest. 2020;: pubmed publisher
  70. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  71. Susa K, Seegar T, Blacklow S, Kruse A. A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking. elife. 2020;9: pubmed publisher
  72. Gang E, Kim H, Hsieh Y, Ruan Y, Ogana H, Lee S, et al. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood. 2020;136:210-223 pubmed publisher
  73. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  74. Tashita C, Hoshi M, Hirata A, Nakamoto K, Ando T, Hattori T, et al. Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice. World J Gastroenterol. 2020;26:918-932 pubmed publisher
  75. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  76. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  77. Fu W, Wang W, Li H, Jiao Y, Weng J, Huo R, et al. High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas. Front Oncol. 2020;10:78 pubmed publisher
  78. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  79. Rodríguez Lorenzo S, Konings J, van der Pol S, Kamermans A, Amor S, van Horssen J, et al. Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells. Acta Neuropathol Commun. 2020;8:9 pubmed publisher
  80. Schommers P, Gruell H, Abernathy M, Tran M, Dingens A, Gristick H, et al. Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody. Cell. 2020;180:471-489.e22 pubmed publisher
  81. Panda S, Wigerblad G, Jiang L, Jiménez Andrade Y, Iyer V, Shen Y, et al. IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints. Proc Natl Acad Sci U S A. 2020;117:3103-3113 pubmed publisher
  82. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  83. Asrat S, Kaur N, Liu X, Ben L, Kajimura D, Murphy A, et al. Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory. Sci Immunol. 2020;5: pubmed publisher
  84. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  85. Gasser P, Tarchevskaya S, Guntern P, Brigger D, Ruppli R, Zbären N, et al. The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab. Nat Commun. 2020;11:165 pubmed publisher
  86. Song S, Li Y, Zhang K, Zhang X, Huang Y, Xu M, et al. Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. J Cancer. 2020;11:142-152 pubmed publisher
  87. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  88. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  89. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  90. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed publisher
  91. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed publisher
  92. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  93. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  94. Götzke H, Kilisch M, Martínez Carranza M, Sograte Idrissi S, Rajavel A, Schlichthaerle T, et al. The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications. Nat Commun. 2019;10:4403 pubmed publisher
  95. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed publisher
  96. Aghajanian H, Kimura T, Rurik J, Hancock A, Leibowitz M, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430-433 pubmed publisher
  97. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  98. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  99. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  100. Barkal A, Brewer R, Markovic M, Kowarsky M, Barkal S, Zaro B, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572:392-396 pubmed publisher
  101. Smillie C, Biton M, Ordovas Montanes J, Sullivan K, Burgin G, Graham D, et al. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. Cell. 2019;178:714-730.e22 pubmed publisher
  102. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  103. Inagaki Katashiba N, Ito T, Inaba M, Azuma Y, Tanaka A, Phan V, et al. Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression. Eur J Immunol. 2019;49:2051-2062 pubmed publisher
  104. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  105. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed publisher
  106. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed publisher
  107. Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S, et al. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 2019;10:951 pubmed publisher
  108. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed publisher
  109. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  110. Rühl J, Citterio C, Engelmann C, Haigh T, Dzionek A, Dreyer J, et al. Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas. J Clin Invest. 2019;129:2071-2087 pubmed publisher
  111. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  112. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  113. Zhang L, Dong X, Lee M, Maslov A, Wang T, Vijg J. Single-cell whole-genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across the human lifespan. Proc Natl Acad Sci U S A. 2019;116:9014-9019 pubmed publisher
  114. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  115. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  116. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  117. Lee S, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Mol Cell. 2019;: pubmed publisher
  118. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  119. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  120. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  121. Chen J, López Moyado I, Seo H, Lio C, Hempleman L, Sekiya T, et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature. 2019;567:530-534 pubmed publisher
  122. Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, et al. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Front Pharmacol. 2019;10:39 pubmed publisher
  123. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  124. Boscheinen J, Thomann S, Knipe D, Deluca N, Schuler Thurner B, Gross S, et al. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA. Front Immunol. 2019;10:2 pubmed publisher
  125. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  126. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed publisher
  127. Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed publisher
  128. Franco L, Gadkari M, Howe K, Sun J, Kardava L, Kumar P, et al. Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses. J Exp Med. 2019;216:384-406 pubmed publisher
  129. Chi V, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, et al. Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC Cancer. 2019;19:81 pubmed publisher
  130. Dagur R, Branch Woods A, Mathews S, Joshi P, Quadros R, Harms D, et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 2019;20:2 pubmed publisher
  131. Schlenner S, Pasciuto E, Lagou V, Burton O, Prezzemolo T, Junius S, et al. NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathology. Ann Rheum Dis. 2019;78:342-349 pubmed publisher
  132. Tan H, Jegaskanda S, Juno J, Esterbauer R, Wong J, Kelly H, et al. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J Clin Invest. 2019;129:850-862 pubmed publisher
  133. Sorrelle N, Ganguly D, Dominguez A, Zhang Y, Huang H, Dahal L, et al. Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues. J Immunol. 2019;202:292-299 pubmed publisher
  134. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  135. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  136. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed publisher
  137. Al Maskari M, Care M, Robinson E, Cocco M, Tooze R, Doody G. Site-1 protease function is essential for the generation of antibody secreting cells and reprogramming for secretory activity. Sci Rep. 2018;8:14338 pubmed publisher
  138. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  139. Bagashev A, Sotillo E, Tang C, Black K, Perazzelli J, Seeholzer S, et al. CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum. Mol Cell Biol. 2018;38: pubmed publisher
  140. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed publisher
  141. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  142. Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, et al. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol. 2018;48:1506-1521 pubmed publisher
  143. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed publisher
  144. Yang X, Zhou J, He J, Liu J, Wang H, Liu Y, et al. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research. Stem Cell Reports. 2018;11:514-521 pubmed publisher
  145. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  146. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed publisher
  147. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  148. Morrissey M, Williamson A, Steinbach A, Roberts E, Kern N, Headley M, et al. Chimeric antigen receptors that trigger phagocytosis. elife. 2018;7: pubmed publisher
  149. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed publisher
  150. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed publisher
  151. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  152. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed publisher
  153. Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, et al. SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. Front Immunol. 2018;9:787 pubmed publisher
  154. He X, Kläsener K, Iype J, Becker M, Maity P, Cavallari M, et al. Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells. EMBO J. 2018;37: pubmed publisher
  155. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed publisher
  156. Liu J, Huang X, Hao S, Wang Y, Liu M, Xu J, et al. Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus. Nat Commun. 2018;9:1136 pubmed publisher
  157. Xiao G, Chan L, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484.e18 pubmed publisher
  158. Vanshylla K, Bartsch C, Hitzing C, Krümpelmann L, Wienands J, Engels N. Grb2 and GRAP connect the B cell antigen receptor to Erk MAP kinase activation in human B cells. Sci Rep. 2018;8:4244 pubmed publisher
  159. Oei V, Siernicka M, Graczyk Jarzynka A, Hoel H, Yang W, Palacios D, et al. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunol Res. 2018;6:467-480 pubmed publisher
  160. Trapecar M, Khan S, Cohn B, Wu F, Sanjabi S. B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol. 2018;11:1158-1167 pubmed publisher
  161. Han S, Yang S, Jo H, Oh Y, Park M, Kim J, et al. BAFF and APRIL expression as an autoimmune signature of membranous nephropathy. Oncotarget. 2018;9:3292-3302 pubmed publisher
  162. Vo L, Kinney M, Liu X, Zhang Y, Barragan J, Sousa P, et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 2018;553:506-510 pubmed publisher
  163. Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681-697 pubmed publisher
  164. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  165. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher
  166. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  167. Krishnan B, Massilamany C, Basavalingappa R, Gangaplara A, Rajasekaran R, Afzal M, et al. Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice. J Immunol. 2018;200:523-537 pubmed publisher
  168. Fry T, Shah N, Orentas R, Stetler Stevenson M, Yuan C, Ramakrishna S, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24:20-28 pubmed publisher
  169. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  170. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed publisher
  171. Tothova Z, Krill Burger J, Popova K, Landers C, Sievers Q, Yudovich D, et al. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017;21:547-555.e8 pubmed publisher
  172. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed publisher
  173. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  174. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  175. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  176. Svensson A, Patzi Churqui M, Schlüter K, Lind L, Eriksson K. Maturation-dependent expression of AIM2 in human B-cells. PLoS ONE. 2017;12:e0183268 pubmed publisher
  177. Delso Vallejo M, Kollet J, Koehl U, Huppert V. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property. Front Immunol. 2017;8:854 pubmed publisher
  178. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  179. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed publisher
  180. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  181. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  182. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  183. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed publisher
  184. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed publisher
  185. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  186. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  187. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
  188. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed publisher
  189. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  190. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  191. Llibre A, Garner L, Partridge A, Freeman G, Klenerman P, Willberg C. Expression of lectin-like transcript-1 in human tissues. F1000Res. 2016;5:2929 pubmed publisher
  192. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed publisher
  193. Johnson S, Dempsey C, Parker C, Mironov A, Bradley H, Saha V. Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton. J Extracell Vesicles. 2017;6:1294339 pubmed publisher
  194. Pyöriä L, Toppinen M, Mäntylä E, Hedman L, Aaltonen L, Vihinen Ranta M, et al. Extinct type of human parvovirus B19 persists in tonsillar B cells. Nat Commun. 2017;8:14930 pubmed publisher
  195. Cooper A, Lill G, Shaw K, Carbonaro Sarracino D, Davila A, Sokolic R, et al. Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. Blood. 2017;129:2624-2635 pubmed publisher
  196. Dourado K, Baik J, Oliveira V, Beltrame M, Yamamoto A, Theuer C, et al. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood. 2017;129:2526-2536 pubmed publisher
  197. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed publisher
  198. Amara K, Clay E, Yeo L, Ramsköld D, Spengler J, Sippl N, et al. B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis. J Autoimmun. 2017;81:34-43 pubmed publisher
  199. van der Velden V, Flores Montero J, Perez Andres M, Martin Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;: pubmed publisher
  200. Shahi P, Kim S, Haliburton J, Gartner Z, Abate A. Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding. Sci Rep. 2017;7:44447 pubmed publisher
  201. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed publisher
  202. Pardi N, Secreto A, Shan X, Debonera F, Glover J, Yi Y, et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017;8:14630 pubmed publisher
  203. Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, et al. Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. Cell. 2017;168:789-800.e10 pubmed publisher
  204. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  205. Perez Ruiz de Garibay A, Spinato C, Klippstein R, Bourgognon M, Martincic M, Pach E, et al. Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy. Sci Rep. 2017;7:42605 pubmed publisher
  206. Canté Barrett K, Mendes R, Li Y, Vroegindeweij E, Pike Overzet K, Wabeke T, et al. Loss of CD44dim Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8:32 pubmed publisher
  207. Aagaard K, Lahon A, Suter M, Arya R, Seferovic M, Vogt M, et al. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication. Sci Rep. 2017;7:41389 pubmed publisher
  208. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed publisher
  209. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  210. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  211. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  212. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  213. van Andel H, Ren Z, Koopmans I, Joosten S, Kocemba K, de Lau W, et al. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proc Natl Acad Sci U S A. 2017;114:376-381 pubmed publisher
  214. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  215. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed publisher
  216. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  217. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  218. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed publisher
  219. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  220. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  221. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed publisher
  222. Oelsner S, Friede M, Zhang C, Wagner J, Badura S, Bader P, et al. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma. Cytotherapy. 2017;19:235-249 pubmed publisher
  223. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  224. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  225. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  226. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed publisher
  227. Casamayor Genescà A, Pla A, Oliver Vila I, Pujals Fonts N, Marín Gallén S, Caminal M, et al. Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells. N Biotechnol. 2017;35:19-29 pubmed publisher
  228. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  229. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  230. Cheeseman H, Olejniczak N, Rogers P, Evans A, King D, Ziprin P, et al. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. J Virol. 2017;91: pubmed publisher
  231. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  232. Chung B, Guevel B, Reynolds G, Gupta Udatha D, Henriksen E, Stamataki Z, et al. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J Autoimmun. 2017;77:45-54 pubmed publisher
  233. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  234. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  235. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  236. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467-E6475 pubmed
  237. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  238. Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed publisher
  239. Willemen Y, Van den Bergh J, Bonte S, Anguille S, Heirman C, Stein B, et al. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells. Oncotarget. 2016;7:73960-73970 pubmed publisher
  240. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed publisher
  241. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  242. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  243. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  244. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  245. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  246. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  247. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  248. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  249. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  250. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  251. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  252. Bentzen A, Marquard A, Lyngaa R, Saini S, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34:1037-1045 pubmed publisher
  253. Toro J, Salgado D, Vega R, Rodríguez J, Rodríguez L, Angel J, et al. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. PLoS ONE. 2016;11:e0161795 pubmed publisher
  254. Huynh L, Kusnadi A, Park S, Murata K, Park Min K, Ivashkiv L. Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Sci Rep. 2016;6:31959 pubmed publisher
  255. Mercer F, Diala F, Chen Y, Molgora B, Ng S, Johnson P. Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis. PLoS Negl Trop Dis. 2016;10:e0004913 pubmed publisher
  256. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed publisher
  257. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed publisher
  258. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  259. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  260. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  261. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  262. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  263. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed publisher
  264. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed publisher
  265. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  266. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  267. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  268. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed publisher
  269. Piancone F, Saresella M, Marventano I, La Rosa F, Zoppis M, Agostini S, et al. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity. Sci Rep. 2016;6:29699 pubmed publisher
  270. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed publisher
  271. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  272. Ellebrecht C, Bhoj V, Nace A, Choi E, Mao X, Cho M, et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science. 2016;353:179-84 pubmed publisher
  273. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
  274. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  275. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed publisher
  276. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  277. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  278. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  279. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  280. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  281. Burger J, Landau D, Taylor Weiner A, Bozic I, Zhang H, Sarosiek K, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat Commun. 2016;7:11589 pubmed publisher
  282. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  283. Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome. Arthritis Res Ther. 2016;18:109 pubmed publisher
  284. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed publisher
  285. Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30 pubmed publisher
  286. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  287. Hohos N, Lee K, Ji L, Yu M, Kandasamy M, Phillips B, et al. DNA cytosine hydroxymethylation levels are distinct among non-overlapping classes of peripheral blood leukocytes. J Immunol Methods. 2016;436:1-15 pubmed publisher
  288. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  289. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  290. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  291. Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed publisher
  292. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  293. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  294. Lisenko K, Schonland S, Jauch A, Andrulis M, Rocken C, Ho A, et al. Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis. Cancer Med. 2016;5:1464-72 pubmed publisher
  295. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  296. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  297. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  298. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  299. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed publisher
  300. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  301. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed publisher
  302. Komori M, Lin Y, Cortese I, Blake A, Ohayon J, Cherup J, et al. Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Ann Clin Transl Neurol. 2016;3:166-79 pubmed publisher
  303. Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60 pubmed publisher
  304. Jardine J, Kulp D, Havenar Daughton C, Sarkar A, Briney B, Sok D, et al. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science. 2016;351:1458-63 pubmed publisher
  305. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed publisher
  306. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed publisher
  307. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  308. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  309. Rombout A, Lust S, Offner F, Naessens E, Verhasselt B, Philippé J. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation. Br J Cancer. 2016;114:704-12 pubmed publisher
  310. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed publisher
  311. Clemente Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature. 2016;530:434-40 pubmed publisher
  312. Klose D, Saunders U, Barth S, Fischer R, Jacobi A, Nachreiner T. Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen. BMC Biotechnol. 2016;16:18 pubmed publisher
  313. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  314. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  315. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  316. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  317. Somasundaram V, Soni S, Chopra A, Rai S, Mahapatra M, Kumar R, et al. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome. Int J Lab Hematol. 2016;38:141-50 pubmed publisher
  318. Dang M, Bradford C, Pozzilli P, Leslie R. Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes. Methods Mol Biol. 2016;1433:143-51 pubmed publisher
  319. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  320. Zhu N, Wang H, Wang B, Wei J, Shan W, Feng J, et al. A Member of the Nuclear Receptor Superfamily, Designated as NR2F2, Supports the Self-Renewal Capacity and Pluripotency of Human Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Int. 2016;2016:5687589 pubmed publisher
  321. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed publisher
  322. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed publisher
  323. Tan J, Pieper K, Piccoli L, Abdi A, Perez M, Geiger R, et al. A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens. Nature. 2016;529:105-109 pubmed publisher
  324. Karlsson H, Svensson E, Gigg C, Jarvius M, Olsson Strömberg U, Savoldo B, et al. Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. PLoS ONE. 2015;10:e0144787 pubmed publisher
  325. Weinstein S, Toker I, Emmanuel R, Ramishetti S, Hazan Halevy I, Rosenblum D, et al. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies. Proc Natl Acad Sci U S A. 2016;113:E16-22 pubmed publisher
  326. Arriaga Pizano L, Ferat Osorio E, Rodríguez Abrego G, Mancilla Herrera I, Domínguez Cerezo E, Valero Pacheco N, et al. Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter. Arch Med Res. 2015;46:651-8 pubmed publisher
  327. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed publisher
  328. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  329. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  330. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed publisher
  331. Günther S, Ostheimer C, Stangl S, Specht H, Mózes P, Jesinghaus M, et al. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer. Front Immunol. 2015;6:556 pubmed publisher
  332. Laner Plamberger S, Lener T, Schmid D, Streif D, Salzer T, Öller M, et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015;13:354 pubmed publisher
  333. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed publisher
  334. Bhat N, Adams C, Chen Y, Bieber M, Teng N. Identification of Cell Surface Straight Chain Poly-N-Acetyl-Lactosamine Bearing Protein Ligands for VH4-34-Encoded Natural IgM Antibodies. J Immunol. 2015;195:5178-88 pubmed publisher
  335. Cox K, Tang A, Chen Z, Horton M, Yan H, Wang X, et al. Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures. MAbs. 2016;8:129-40 pubmed publisher
  336. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed publisher
  337. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed publisher
  338. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  339. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  340. Dai B, Chen A, Corkum C, Peroutka R, Landon A, Houng S, et al. Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders. Oncogene. 2016;35:2979-90 pubmed publisher
  341. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed publisher
  342. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  343. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed publisher
  344. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  345. Andersson K, Brisslert M, Cavallini N, Svensson M, Welin A, Erlandsson M, et al. Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. Oncotarget. 2015;6:20043-57 pubmed
  346. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed publisher
  347. Cui X, Zhang L, Magli A, Catera R, Yan X, Griffin D, et al. Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability. Leukemia. 2016;30:74-85 pubmed publisher
  348. Wostradowski T, Gudi V, Pul R, Gingele S, Lindquist J, Stangel M, et al. Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients. Clin Exp Immunol. 2015;182:162-72 pubmed publisher
  349. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  350. Chalan P, Bijzet J, Huitema M, Kroesen B, Brouwer E, Boots A. Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis. PLoS ONE. 2015;10:e0132436 pubmed publisher
  351. Saulep Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C, et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 2016;30:163-72 pubmed publisher
  352. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  353. Elong Ngono A, Lepetit M, Reindl M, Garcia A, Guillot F, Genty A, et al. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis. J Immunol Res. 2015;2015:673503 pubmed publisher
  354. Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation. 2015;12:119 pubmed publisher
  355. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  356. Rasmussen T, Andersen T, Bak R, Yiu G, Sørensen C, Stengaard Pedersen K, et al. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Res Ther. 2015;17:154 pubmed publisher
  357. Wielgosz M, Kim Y, Carney G, Zhan J, Reddivari M, Coop T, et al. Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy. Mol Ther Methods Clin Dev. 2015;2:14063 pubmed publisher
  358. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed publisher
  359. Kerkman P, Fabre E, van der Voort E, Zaldumbide A, Rombouts Y, Rispens T, et al. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75:1170-6 pubmed publisher
  360. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed publisher
  361. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  362. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed publisher
  363. Zhu D, Wang Z, Zhao J, Calimeri T, Meng J, Hideshima T, et al. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med. 2015;21:572-80 pubmed publisher
  364. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  365. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed publisher
  366. Wang Z, Wan Y, Qiu C, Quiñones Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells. Nat Commun. 2015;6:6833 pubmed publisher
  367. de Winde C, Zuidscherwoude M, Vasaturo A, van der Schaaf A, Figdor C, van Spriel A. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs. Histochem Cell Biol. 2015;144:133-46 pubmed publisher
  368. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  369. Bhat N, Kshirsagar M, Bieber M, Teng N. IgG Subclasses and Isotypes of VH4-34 Encoded Antibodies. Immunol Invest. 2015;44:400-10 pubmed publisher
  370. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  371. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  372. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  373. Mahmood Z, Muhammad K, Schmalzing M, Roll P, Dörner T, Tony H. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Arthritis Res Ther. 2015;17:61 pubmed publisher
  374. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  375. Schilling D, Kühnel A, Tetzlaff F, Konrad S, Multhoff G. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells. Cancer Immunol Immunother. 2015;64:599-608 pubmed publisher
  376. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed publisher
  377. Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed publisher
  378. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  379. Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136:692-702.e2 pubmed publisher
  380. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  381. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed publisher
  382. Holmfeldt L, Mullighan C. Generation of human acute lymphoblastic leukemia xenografts for use in oncology drug discovery. Curr Protoc Pharmacol. 2015;68:14.32.1-19 pubmed publisher
  383. Martínez Torres A, Quiney C, Attout T, Boullet H, Herbi L, Vela L, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. PLoS Med. 2015;12:e1001796 pubmed publisher
  384. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  385. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  386. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  387. García Carmona Y, Cols M, Ting A, Radigan L, Yuk F, Zhang L, et al. Differential induction of plasma cells by isoforms of human TACI. Blood. 2015;125:1749-58 pubmed publisher
  388. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed publisher
  389. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  390. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed publisher
  391. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  392. Li P, Feng L, Chen N, Ge X, Lv X, Lu K, et al. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway. Med Oncol. 2015;32:479 pubmed publisher
  393. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  394. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed publisher
  395. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed publisher
  396. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed publisher
  397. Hagberg N, Theorell J, Hjorton K, Spee P, Eloranta M, Bryceson Y, et al. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67:1000-11 pubmed publisher
  398. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  399. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  400. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed publisher
  401. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  402. Meinke P, Schneiderat P, Srsen V, Korfali N, Lê Thành P, Cowan G, et al. Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord. 2015;25:127-36 pubmed publisher
  403. Tungatt K, Bianchi V, Crowther M, Powell W, Schauenburg A, Trimby A, et al. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs. J Immunol. 2015;194:463-74 pubmed publisher
  404. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  405. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  406. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  407. Sahler J, Woeller C, Phipps R. Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytes. PLoS ONE. 2014;9:e113189 pubmed publisher
  408. Williams D, Anastos K, Morgello S, Berman J. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97:401-12 pubmed publisher
  409. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  410. Chow I, Yang J, Gates T, James E, Mai D, Greenbaum C, et al. Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121-140 and GAD65 250-266 in T1D development. PLoS ONE. 2014;9:e112882 pubmed publisher
  411. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  412. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  413. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed publisher
  414. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed publisher
  415. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed publisher
  416. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed publisher
  417. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  418. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed publisher
  419. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed publisher
  420. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  421. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  422. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  423. Schneider Hohendorf T, Rossaint J, Mohan H, Böning D, Breuer J, Kuhlmann T, et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med. 2014;211:1833-46 pubmed publisher
  424. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  425. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed publisher
  426. Chung Y, Kim E, Abdel Wahab O. Femoral bone marrow aspiration in live mice. J Vis Exp. 2014;: pubmed publisher
  427. Feng Y, Zhang N, Jacobs K, Jiang W, Yang L, Li Z, et al. Polarization imaging and classification of Jurkat T and Ramos B cells using a flow cytometer. Cytometry A. 2014;85:817-26 pubmed publisher
  428. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  429. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  430. Herrera A, Kim H, Bindra B, Jones K, Alyea E, Armand P, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1737-43 pubmed publisher
  431. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  432. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  433. Gomez A, Willcox N, Vrolix K, Hummel J, Nogales Gadea G, Saxena A, et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 2014;193:1055-1063 pubmed publisher
  434. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed publisher
  435. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed publisher
  436. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  437. Rossi E, Chang C, Goldenberg D. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus. PLoS ONE. 2014;9:e98315 pubmed publisher
  438. Weber G, Chousterman B, Hilgendorf I, Robbins C, Theurl I, Gerhardt L, et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med. 2014;211:1243-56 pubmed publisher
  439. Demberg T, Mohanram V, Venzon D, Robert Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin Immunol. 2014;153:264-76 pubmed publisher
  440. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  441. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed publisher
  442. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  443. Schuler P, Saze Z, Hong C, Muller L, Gillespie D, Cheng D, et al. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol. 2014;177:531-43 pubmed publisher
  444. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  445. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed publisher
  446. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  447. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher
  448. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  449. Ilander M, Kreutzman A, Rohon P, Melo T, Faber E, Porkka K, et al. Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-? monotherapy. PLoS ONE. 2014;9:e87794 pubmed publisher
  450. Nikitin P, Price A, McFadden K, Yan C, Luftig M. Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest. PLoS ONE. 2014;9:e87299 pubmed publisher
  451. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  452. Ataide M, Andrade W, Zamboni D, Wang D, Souza M, Franklin B, et al. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 2014;10:e1003885 pubmed publisher
  453. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed publisher
  454. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  455. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  456. Herting F, Friess T, Bader S, Muth G, Hölzlwimmer G, Rieder N, et al. Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma. Leuk Lymphoma. 2014;55:2151-5160 pubmed publisher
  457. Elias S, Choudhary P, de Cassan S, Biswas S, Collins K, Halstead F, et al. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology. 2014;141:628-44 pubmed publisher
  458. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  459. Adams R, Cheung C, Banh R, Saal R, Cross D, Gill D, et al. Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry. Cytometry B Clin Cytom. 2014;86:80-90 pubmed
  460. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed publisher
  461. Lighaam L, Vermeulen E, Bleker T, Meijlink K, Aalberse R, Barnes E, et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2014;133:267-70.e1-6 pubmed publisher
  462. Raghunathan R, Mahesula S, Kancharla K, Janardhanan P, Jadhav Y, Nadeau R, et al. Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALL. Part Part Syst Charact. 2013;30:355-364 pubmed
  463. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  464. Barua S, Iyer J, Larabee J, Raisley B, Hughes M, Coggeshall K, et al. Toxin inhibition of antimicrobial factors induced by Bacillus anthracis peptidoglycan in human blood. Infect Immun. 2013;81:3693-702 pubmed publisher
  465. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  466. Pala P, Serwanga J, Watera C, Ritchie A, Moodie Z, Wang M, et al. Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners. J Virol. 2013;87:9053-63 pubmed publisher
  467. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed publisher
  468. Parzych E, Li H, Yin X, Liu Q, Wu T, Podsakoff G, et al. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther. 2013;24:431-42 pubmed publisher
  469. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed publisher
  470. De Oliveira S, Wang J, Ryan C, Morrison S, Kohn D, Hollis R. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors. J Transl Med. 2013;11:23 pubmed publisher
  471. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed publisher
  472. Ekeruche Makinde J, Clement M, Cole D, Edwards E, Ladell K, Miles J, et al. T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem. 2012;287:37269-81 pubmed publisher
  473. Kvistborg P, Shu C, Heemskerk B, Fankhauser M, Thrue C, Toebes M, et al. TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology. 2012;1:409-418 pubmed
  474. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  475. McArthur M, Sztein M. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS ONE. 2012;7:e38408 pubmed publisher
  476. Dorvignit D, Palacios J, Merino M, Hernández T, Sosa K, Casaco A, et al. Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study. MAbs. 2012;4:488-96 pubmed publisher
  477. Lyke K, Dabo A, Arama C, Daou M, Diarra I, Wang A, et al. Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium. PLoS ONE. 2012;7:e31647 pubmed publisher
  478. Man S, Tucky B, Cotleur A, Drazba J, Takeshita Y, Ransohoff R. CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier. Sci Transl Med. 2012;4:119ra14 pubmed publisher
  479. Frasca D, Diaz A, Romero M, Phillips M, Mendez N, Landin A, et al. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol. 2012;24:175-82 pubmed publisher
  480. Hirao L, Hokey D, Morrow M, Jure Kunkel M, Weiner D. Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge. PLoS ONE. 2011;6:e24250 pubmed publisher
  481. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed publisher
  482. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed publisher
  483. Li H, Lasaro M, Jia B, Lin S, Haut L, High K, et al. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther. 2011;19:2021-30 pubmed publisher
  484. Lee J, Hayman E, Pegram H, Santos E, Heller G, Sadelain M, et al. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy. Cancer Res. 2011;71:2871-81 pubmed publisher
  485. Berthoud T, Hamill M, Lillie P, Hwenda L, Collins K, Ewer K, et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis. 2011;52:1-7 pubmed publisher
  486. Mizuochi T, Ito M, Takai K, Yamaguchi K. Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients. Virus Res. 2011;155:349-51 pubmed publisher
  487. Rawstron A, Shingles J, de Tute R, Bennett F, Jack A, Hillmen P. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing. Cytometry B Clin Cytom. 2010;78 Suppl 1:S42-6 pubmed publisher
  488. Mizuochi T, Ito M, Saito K, Kasai M, Kunimura T, Morohoshi T, et al. Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B cells to the liver of chronic hepatitis C patients. J Interferon Cytokine Res. 2010;30:243-52 pubmed publisher
  489. Schmetterer K, Seidel M, Körmöczi U, Rottal A, Schwarz K, Matthes Martin S, et al. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels. Int Arch Allergy Immunol. 2010;152:390-400 pubmed publisher
  490. Fung E, Esposito L, Todd J, Wicker L. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc. 2010;5:357-70 pubmed publisher
  491. Marino J, Tan C, Taylor A, Bentley C, Van De Wiele C, Ranne R, et al. Differential IL-7 responses in developing human thymocytes. Hum Immunol. 2010;71:329-33 pubmed publisher
  492. Erlendsson L, Muench M, Hellman U, Hrafnkelsdóttir S, Jonsson A, Balmer Y, et al. Barley as a green factory for the production of functional Flt3 ligand. Biotechnol J. 2010;5:163-71 pubmed publisher
  493. Mizuochi T, Ito M, Takai K, Yamaguchi K. Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients. Biochem Biophys Res Commun. 2009;389:512-5 pubmed publisher
  494. Göbel F, Taschner S, Jurkin J, Konradi S, Vaculik C, Richter S, et al. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood. 2009;114:3813-21 pubmed publisher
  495. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed publisher
  496. Hokey D, Yan J, Hirao L, Dai A, Boyer J, Jure Kunkel M, et al. CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8 T cells and a more persistent central memory CD4 T cell response. J Med Primatol. 2008;37 Suppl 2:62-8 pubmed publisher
  497. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed publisher
  498. Wang J, Kobie J, Zhang L, Cochran M, Mosmann T, Ritchlin C, et al. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods. 2009;341:106-16 pubmed publisher
  499. Giannelli S, Taddeo A, Presicce P, Villa M, Della Bella S. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry B Clin Cytom. 2008;74:349-55 pubmed publisher
  500. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed publisher
  501. Hokey D, Johnson F, Smith J, Weber J, Yan J, Hirao L, et al. Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. Eur J Immunol. 2008;38:1435-45 pubmed publisher
  502. Sathler Avelar R, Vitelli Avelar D, Massara R, de Lana M, Pinto Dias J, Teixeira Carvalho A, et al. Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect. 2008;10:103-13 pubmed publisher
  503. Martins M, Silva M, Marciano A, Peruhype Magalhães V, Eloi Santos S, Ribeiro J, et al. Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?. Clin Exp Immunol. 2007;148:90-100 pubmed
  504. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  505. Williams M, Densmore J, Pawluczkowycz A, Beum P, Kennedy A, Lindorfer M, et al. Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia. J Immunol. 2006;177:7435-43 pubmed
  506. Bojarska Junak A, Giannopoulos K, Kowal M, Dmoszynska A, Rolinski J. Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL). Cytometry B Clin Cytom. 2006;70:293-301 pubmed
  507. Campbell R, Manyak S, Yang H, Sjak Shie N, Chen H, Gui D, et al. LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma. Int J Oncol. 2006;28:1409-17 pubmed
  508. Timeus F, Crescenzio N, Sanavio F, Fazio L, Doria A, Foglia L, et al. Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice. Haematologica. 2006;91:369-72 pubmed
  509. Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694-701 pubmed
  510. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  511. del Giudice I, Matutes E, Morilla R, Morilla A, Owusu Ankomah K, Rafiq F, et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica. 2004;89:303-8 pubmed
  512. Yokota T, Meka C, Kouro T, Medina K, Igarashi H, Takahashi M, et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol. 2003;171:5091-9 pubmed
  513. Kivisakk P, Mahad D, Callahan M, Trebst C, Tucky B, Wei T, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A. 2003;100:8389-94 pubmed
  514. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  515. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  516. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  517. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  518. Minguela A, Marin L, Torio A, Muro M, Garcia Alonso A, Moya Quiles M, et al. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant. Hum Immunol. 2000;61:658-69 pubmed
  519. Eksioglu Demiralp E, Budak Alpdogan T, Alpdogan O, Atalay A, Ratip S, Oz D, et al. Double G0/G1 peak in the DNA histogram of aberrant marker positive acute leukemia patients is associated with a poor clinical outcome. Leuk Lymphoma. 1999;33:567-72 pubmed
  520. Cabezudo E, Carrara P, Morilla R, Matutes E. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Haematologica. 1999;84:413-8 pubmed
  521. Nomdedeu J, Mateu R, Altes A, Llorente A, Rio C, Estivill C, et al. Enhanced myeloid specificity of CD117 compared with CD13 and CD33. Leuk Res. 1999;23:341-7 pubmed
  522. Muench M, Roncarolo M, Menon S, Xu Y, Kastelein R, Zurawski S, et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood. 1995;85:963-72 pubmed